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ABSTRACT OF THE DISSERTATION 
Identification and characterization of novel astroviruses 
by 
Stacy Renee Finkbeiner 
 
Approximately 1.8 million children die from diarrhea annually, and millions 
more suffer multiple episodes of nonfatal diarrhea. Despite the availability 
of improved molecular diagnostics to detect the known viral agents, the 
etiology of a large proportion of diarrheal cases is unknown. In fact, it is 
estimated that no causative agent can be identified in up to 40% of 
sporadic cases or in gastroenteritis outbreaks. Detection of novel or 
unexpected viruses is the first step in identifying agents that could 
potentially close the diagnostic gap and pave the way for the 
development of more comprehensive preventative measures and better 
treatments.  
 This dissertation encompasses the first application of cutting edge 
mass sequencing approaches to the analysis of viruses present in fecal 
specimens from patients with diarrhea. Known enteric viruses as well as 
multiple sequences (with only limited sequence similarity to viruses in 
GenBank) from putatively novel viruses were detected in pediatric 
sporadic diarrhea specimens. One virus, Astrovirus MLB1 (AstV-MLB1), was 
fully sequenced and determined to be a highly divergent, novel astrovirus 
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based on phylogenetic analysis. AstV-MLB1 was further detected by RT-
PCR in 4/254 fecal specimens collected at the St. Louis Children’s hospital 
in 2008, indicating that AstV-MLB1 is currently circulating in North America.  
 A second highly divergent, novel astrovirus, Astrovirus VA1 (AstV-
VA1), was identified in two specimens from a gastroenteritis outbreak at a 
child care center.  Mass sequencing yielded nearly the entire genome of 
AstV-VA1 which appears to be most closely related to astroviruses found 
in mink and sheep.  One additional sample also tested positive for AstV-
VA1 by RT-PCR, resulting in detection of the virus in 3/5 specimens 
collected from the outbreak.  This presents the possibility that further 
investigations might reveal that AstV-VA1 is a causative agent of 
gastroenteritis outbreaks. 
 The identification of two novel astroviruses in fecal specimens from 
children with diarrhea suggests that astroviruses may cause a larger 
fraction of diarrhea cases than previously recognized. Furthermore, the 
identification and characterization of novel astroviruses MLB1 and VA1 
lays the foundation for future investigations into their potential roles as 
etiologic agents of diarrhea. 
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Chapter 1: Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portions of this chapter will be published in “New Virus Discovery in the 21st 
Century.” Molecular Microbiology: Diagnostic Principles and Practice. ASM Press  
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Background on detection of novel viruses 
 The detection of novel viruses has traditionally relied heavily on the 
ability to culture viruses in a laboratory setting. This has limited our ability to 
detect a large number of viruses due to the fact that many viruses do not 
grow well, or at all, in cell culture.  Of the ones that do grow in cell culture, 
it is often a tedious process to determine a permissive cell line(s) in 
combination with the optimal culturing conditions that allow a virus to be 
successfully propagated. Furthermore, the ability to culture a virus does 
not inherently lead to easy identification or characterization of the virus. In 
the past, the identification and characterization of unknown viruses grown 
in culture was based primarily on visual inspection of viral particle size and 
morphology using electron microscopy (EM) or serological cross reactivity 
with antibodies to known viruses. The ability to determine the viral family to 
which a given virus belongs to based on EM observations is severely 
hampered by the fact that many viral families exhibit similar morphologies, 
making it difficult to easily distinguish between them. Serological assays 
also have their limitations in that the unknown virus must cross react with a 
known virus for which there are serological reagents available. It also 
requires having some a priori knowledge about the possible identity of the  
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Figure 1.1: Methods for virus discovery in the past 20 years 
 
unknown virus, since screening has to be done individually for each viral 
family.  
Since the advent of the polymerase chain reaction (PCR) in the 
1980s, PCR has become a common method for detecting viral genomes.   
Once the genome sequence for a given virus is available, it is a 
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straightforward endeavor to design primers that detect the target virus.  
Application of PCR to highly conserved regions of a given virus family or 
taxa has enabled the identification of many novel viruses related to 
known viral families, much as PCR targeting 16S ribosomal genes in 
bacteria has resulted in the identification of novel bacteria.  While the 
cases of viruses discovered in this fashion are too numerous to 
exhaustively list, some notable examples include sin nombre virus (Figure 
1.1A) [1] and human coronavirus HKU1 [2]. Various computational 
strategies for design of consensus PCR primers for novel virus identification 
have been described [3,4]. However, one fundamental limitation of PCR 
assays, which is shared with serological approaches, is that the breadth of 
these assays is limited to interrogating a single taxa, typically a given viral 
family.  Thus, one must have some idea of which viral family or families one 
wants to examine, which can be a daunting task given the abundance of 
possibilities.  
As a consequence of these limitations, other methods not subject to 
this form of bias, such as representational difference analysis (RDA) [5], 
have been applied to virus discovery. This method is a form of subtractive 
hybridization involving the hybridization of nucleic acids between 
putatively infected samples and carefully chosen controls (uninfected 
samples).  Unique sequences present only in the infected specimens are 
preferentially amplified during subsequent PCR cycles leading to 
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dramatic enrichment for the unique sequences.  The most notable 
application of RDA to date resulted in the identification of human 
herpesvirus-8 in Kaposi’s Sarcoma lesions (Figure 1.1A) [6].  Following this 
landmark event in the use of molecular methods for virus discovery, many 
other efforts to use RDA to identify novel viruses ensued, but generally with 
only limited success.   In one recent successful case, RDA was used to 
identify viral sequences from the novel murine norovirus 1 following serial 
passage of a putative infectious agent in mice lacking innate immunity, 
which effectively served to amplify the virus to much higher titers in vivo 
[7].   A major technical limitation is that it is difficult to obtain a well 
matched negative control for the specimen of interest, and frequently the 
amplified differences between the samples reflect differences in host 
gene expression rather than foreign microbial sequences.    
Another landmark discovery, that of hepatitis C, relied upon a 
unique strategy that combined both molecular cloning techniques with 
serological methods [8]. In cDNA library immunoscreening (Figure 1.1A), 
nucleic acids were extracted from putatively infected specimens and 
used to generate bacterial cDNA clones.  Serum from a patient suffering 
from non-A, non-B hepatitis was used to screen the cDNA clones to 
identify polypeptides that were bound by serum antibodies. One reactive 
clone was identified that contained an insert that was not present in 
control samples.  Furthermore, the sequence of this clone did not hybridize 
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to host sequences, suggesting that the clone represented sequence 
unique to the infected sample.  Sequencing of the clone yielded a new 
member of the Flavivirus family, hepatitis C virus.  While this technique 
identified the etiologic agent of non-A, non-B hepatitis, its application to 
other diseases has been limited, and no other significant viruses have 
been identified to date using this approach.  
 
The 1st decade of the 21st century:  the Dawn of Sequence based 
Discovery Methods  
Sequence-independent PCR strategies and new technologies such 
as microarrays and mass sequencing, while not without their own 
limitations, circumvent many of the limitations associated with traditional 
virus discovery methods and consequently have revolutionized the 
process of virus discovery. These approaches, which can be applied 
either alone or in concert with traditional methods such as tissue culture, 
have enabled unbiased and massively parallel analysis of the nucleic 
acid composition of a given specimen.   It must be emphasized however, 
that these approaches complement and do not replace traditional 
virologic methods.  For example, recent discoveries of viruses, such as 
Chapare hemorrhagic fever virus [9] and Melaka virus, a zoonotic bat 
virus associated with respiratory disease [10], continue to demonstrate the 
effectiveness of culture and serological methods.  However, it is clear that 
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there are viruses that do not grow in culture or that are so highly divergent 
that they are not amenable to traditional methods but can be unveiled 
by these newer molecular methods.    In this review, we will focus on those 
viruses where molecular methods have played a critical role in their 
discovery.  
 
Sequence-independent PCR amplification strategies for virus detection 
  PCR screening for novel viruses using primers designed to 
conserved features of viral families offers a powerful approach to virus 
identification, provided there is adequate rationale to select a given 
candidate viral family to test.  In the absence of a logical set of 
candidates to screen, it is typically not feasible to target every viral family 
individually, which would be prohibitively laborious, time-intensive, and 
reagent intensive.  The development of methods in which nucleic acids 
could be amplified in the absence of primers designed to a specific 
target sequence has played a critical role in the latest methods for virus 
discovery.  These sequence independent methods are capable of 
increasing the quantity of an unknown agent to detectable levels.   
Various post amplification detection strategies have been devised to 
‘visualize’ the products of interest that include gel electrophoresis based 
differential display approaches (e.g. VIDISCA), hybridization to pan viral 
microarrays, and high throughput mass sequencing. 
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Identification of human metapneumovirus. The discovery of a novel 
human pneumovirus in 2001, called human metapneumovirus (hMPV), 
relied upon a sequence independent PCR approach in conjunction with 
viral culture to identify a previously unknown virus. [11]. In this study, 28 
serologically related, but otherwise unidentifiable viruses were isolated in 
cell culture from patients with respiratory tract infections. One of the virus 
isolates grown in cell culture was amplified using a technique called 
arbitrarily primed PCR [12,13]. In this technique, primers such as the 
commonly used Universal M13, T7, and T3 primers are arbitrarily selected 
for use in amplification. The amplification scheme involves low stringency 
annealing in the early cycles so that mismatches will be accommodated 
during the annealing of the primers to many different sequences in the 
sample. In the later cycles, a higher stringency annealing temperature is 
used in which amplicons that can be efficiently amplified will 
predominate and create a fingerprint of the sample. The fingerprint, 
consisting of various sized amplicons, can then be compared to control 
samples in order to identify the unique PCR products to then be 
subsequently sequenced. In the case of hMPV, 10/20 PCR products that 
were sequenced had amino acid similarity to avian pneumovirus (APV). 
Upon further sequencing, it was determined that this novel virus encoded 
proteins that were 52-87% similar to avian pneumovirus at the amino acid 
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level. Preliminary animal studies showed that hMPV was able to replicate 
and cause mild upper respiratory symptoms in monkeys, but did not cause 
any symptoms in birds nor showed any signs of replication. Finally, the 
seroprevalence of hMPV was shown to be 100% by age 5. As a result of 
numerous follow up studies [14], it is now believed that hMPV is a 
significant cause of respiratory tract infections. It is interesting to note that 
the initial report of hMPV also noted that hMPV has been circulating in the 
human population for at least 50 years, but that it eluded detection 
because it did not grow well under typical cell culturing conditions, it had 
low nucleotide similarity to known viruses, and lacked apparent 
serological cross reactivity with antibodies generated against other viruses.  
 
Viruses identified using DNase-SISPA. Another approach known as 
sequence-independent single primer amplification (SISPA) [15] involves 
the ligation of a common primer binding sequence to both ends of cDNA 
molecules, which can then be amplified with a cognate primer. A 
refinement of this approach called DNase-SISPA involves the treatment of 
samples with DNase prior to nucleic acid extraction  [16]. The theory 
behind DNase-SISPA is that the DNase should degrade host DNA, but viral 
nucleic acid should be protected by the protein capsid and for some 
viruses also by the lipid viral envelope. Therefore, nucleic acids that survive 
the DNase treatment step should be enriched for sequences of viral origin. 
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In the initial description of the method, the extracted nucleic acid was 
digested using restriction enzymes and the resulting restriction fragments 
were then subjected to SISPA. The SISPA products were visualized by gel 
electrophoresis and prominent bands were sequenced. Amplicons 
derived from novel bovine parvoviruses were identified in this initial proof 
of concept (Figure 1.1B).  Subsequently, DNase-SISPA has been used to 
identify novel viruses from human plasma (parvovirus 4 (PARV4) and two 
TTV-like anelloviruses [17]).  PARV4 has since been detected in human 
serum in multiple studies, but its role in human disease is not currently 
known.   In addition, application of DNase-SISPA to tissue cultures 
inoculated with human stools has led to identification of the novel human 
adenovirus 52 (HAdV-52) [18] and a novel cardiovirus, Saffold virus (SAF-V) 
[19].  Multiple other studies have since demonstrated that viruses related 
to Saffold are circulating in the human population [20-22]. The fact that 
novel viruses from multiple different viral families have been identified with 
this approach highlights its utility as an unbiased means for viral discovery.   
 
 Viruses identified using VIDISCA. Another approach called VIDISCA, 
which stands for Virus-Discovery-cDNA-amplified restriction fragment-
length polymorphism, was used in the discovery of a novel human 
coronavirus, NL63 (HCoV-NL63), in 2004 (Figure 1.1B) [23]. Like DNase-SISPA, 
the VIDISCA method begins with a viral enrichment step that entails 
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centrifugation to remove residual cells and mitochondria and then DNase 
treatment to degrade non-enveloped or non-encapsidated DNA.  Upon 
RNA extraction, double stranded cDNA is synthesized and then the cDNA 
is digested with restriction enzymes that are known to cut frequently 
occurring DNA sequences so as to generate smaller amplifiable 
sequences. Two different adapters are ligated onto the cDNA fragments 
so that only sequences which have a different adapter on each end can 
be subsequently amplified. To clearly visualize the products following gel 
electrophoresis and compare the products to those obtained from a 
control sample, another round of amplification reactions is carried out in 
which the adapter primers are modified to include one extra random 
nucleotide. Since one random nucleotide is added to each primer, there 
are a total of 4 variations of each of the two different adapter primers 
that can be used in 16 primer pair combinations to amplify subsets of the 
original pool of amplicons.  Bands present in the experimental sample 
lanes that are absent in the controls are excised from the gel and 
sequenced. 
The first application of VIDISCA to virus discovery resulted in the 
identification of human coronavirus NL63 (Figure 1.1B). An unidentified 
virus was propagated in tertiary monkey kidney cells after inoculation of a 
nasopharyngeal aspirate from a patient with respiratory infection.   
VIDSCA was performed on the supernatant from the infected cells and a 
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cell culture supernatant from uninfected cells was used as a negative 
control. PCR bands that were specific to the virus infected sample and 
not present in the uninfected control were then sequenced. The initial 
fragments shared limited sequence identity to known coronaviruses. 
Subsequently, the full genome of a novel coronavirus was sequenced that 
shared on average 65% identity to its closest relative HCoV-229E. 
Furthermore, HCoV-NL63 contained unique genomic features, such as an 
insertion in the spike protein, which is involved in receptor binding and is 
thought to determine the tropism of the virus. In the original study, HCoV-
NL63 was also detected in up to 7% of patients with respiratory disease.  A 
follow-up study suggested that NL63 is associated with croup [24].   Shortly 
following the identification of NL63, yet another coronavirus, HKU1, was 
discovered using degenerate PCR screening strategy [2].   The 
identification of these two human viruses immediately following the SARS-
coronavirus outbreak of 2003 has greatly increased awareness of the role 
of coronaviruses in human disease, and suggested that the importance of 
coronaviruses as etiologic agents of respiratory infections and their 
diversity has been vastly underestimated. VIDISCA has also been used to 
identify a new strain of human parechovirus type 1 [25].  
These examples used sequence-independent PCR assays followed 
by selective sequencing of a subset of “unique” PCR products and have 
highlighted how powerful unbiased approaches are in the discovery of 
 - - 13 - - 
novel viruses. In many ways, these techniques provide the foundation for 
the higher-throughput techniques that will be discussed in the rest of this 
chapter.  
 
Sequence independent PCR followed by microarray hybridization for virus 
discovery 
 DNA microarrays first emerged in the mid 1990s as powerful tools to 
measure gene expression or genomic content changes in various 
organisms [26-28]. While many flavors of microarrays exist, the 
commonality to all microarrays is that a high density of DNA probes, 
numbering from thousands to hundreds of thousands,  is attached to a 
surface or surfaces enabling the analysis of complex mixtures of input 
nucleic acid [26-28] in a single assay.  Capitalizing on the inherently 
massively parallel nature of microarrays, Wang et al. described in 2002 the 
first microarray designed to detect large numbers of viruses [29].  This 
prototype DNA microarray (the “ViroChip”) harbored 1,600 70mer 
oligonucleotides derived from 140 different virus species with an average 
of ~ 10 oligonucleotides per virus species.  Conventionally, microarrays 
had been designed primarily with probes from a single organism of 
interest.  The rationale for development of this microarray was twofold:  (1) 
the microarray would enable simultaneous screening for hundreds to 
thousands of known viruses in a single assay, thus making it an ideal 
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diagnostic tool; (2) by careful selection of highly conserved sequences, it 
was anticipated that novel viruses related to known virus families could be 
detected.   
  Experimentally, viral nucleic acids extracted from clinical samples 
are subject to random PCR amplification, fluorescently labeled and 
hybridized to the microarray.  The resulting hybridization patterns observed 
between the nucleic acids in the sample and the oligonucleotides on the 
array can be analyzed to identify whether a known or novel virus is 
present in the sample. The performance of the ViroChip was validated on 
both cultured viruses as well as on clinical samples.   It was demonstrated 
that a wide variety of viruses could be detected by the array, including 
representatives of both RNA and DNA viruses [29].  With the development 
of this technology, it quickly became apparent that objective 
computational approaches for analysis and interpretation of the raw 
microarray data were needed.   In 2005, the first algorithm for objectively 
interpreting microarray hybridization data to infer the presence of 
microbial species, E-predict, was described [30].   In one follow-up study, 
the ViroChip detected known viruses in 53/82 (65%) nasal lavage samples 
whereas only 14 (17%) of these samples yielded viruses by culture  [31].   In 
another follow-up study, the ViroChip demonstrated sensitivity in the 
range of 85-90% and specificity of ≥99%, as compared to virus specific 
PCR/RT-PCR reactions for respiratory syncytial virus, influenza and rhinovirus 
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[32].   These results demonstrated the feasibility of using sequence 
independent PCR amplification of clinical specimens in combination with 
microarrays to detect a broad range of known viruses.  Critically, in 
contrast to traditional screening strategies, a priori assumptions regarding 
the types of virus present do not need to be made. 
DNA microarrays using long (70mer) oligonucleotide probes have 
also proven to be more robust to viral mutations than conventional PCR.  
For example, in one case, ViroChip analysis indicated that a patient 
specimen contained human metapneumovirus even though multiple 
assays using metapneumovirus PCR primers were negative.   Sequencing 
of the virus present in the sample ultimately revealed that mutations 
present in the primer binding sites were most likely the cause of the false 
negative PCR result [33].  This case illustrates two features of microarray 
based diagnostics:  (1) depending on the length of the microarray probe, 
varying degrees of mutation can be tolerated, enabling detection of 
variant species; (2) the presence of multiple oligonucleotide probes for 
each target virus (i.e. redundancy) provides greater opportunities to 
detect variant viruses.   
The field of diagnostic microarrays has grown tremendously in the 
past few years, with multiple broad-range diagnostic microarrays 
described [34-37]. These have utilized a multitude of different microarray 
platforms, probe design strategies, and oligonucleotides of varying 
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lengths, demonstrating the robustness of the general methodology.  In 
parallel, there has been more limited progress in the development of 
algorithms for interpretation of diagnostic microarrays [38,39].   The 
published applications of these diagnostic microarrays to date have 
focused exclusively on detection of known viruses.  By contrast, the 
second goal in development of the ViroChip was to facilitate the 
discovery of novel viruses.  To date, this approach has been used to 
identify a number of novel viruses, from humans and animals.  
 
 Identification of SARS-CoV.  The World Health Organization (WHO) 
issued a global alert in 2003 regarding an illness described as “severe 
acute respiratory syndrome” (SARS) that was emerging in Southeast Asia 
with significant mortality.  A WHO coordinated collaboration was 
established between labs around the world to try and identify the 
causative agent of the highly contagious illness that had rapidly spread 
from Asia to other parts of the world. This was the first case in which a DNA 
microarray was employed to detect a novel virus (Figure 1.1B).  The then 
unknown virus was cultured in Vero cells [40].  Extraction of total nucleic 
acids from the culture followed by random amplification and hybridization 
to the ViroChip [41] yielded a significant signal intensity from just a few 
oligonucleotides derived from the viral families Coronaviridae and 
Astroviridae. Given the limited number of oligonucleotides that were 
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hybridized to the sample, it appeared that there may have been two 
novel viruses present in the sample. However, further analysis revealed 
that all of the oligonucleotides derived from the Astroviridae family came 
from a genetic element that is found in the 3’ untranslated region of the 
genomes of both viral families [42]. Therefore, based on the nature of the 
hybridization pattern, it appeared that a single virus, likely a coronavirus, 
was present in the sample.  Since only a small subset of the highly 
conserved probes from the family Coronaviridae were bound by the virus, 
it was reasoned that the virus was likely to be highly divergent.   In order to 
rapidly sequence parts of the novel virus genome, cDNA fragments 
derived from the unknown virus were physically recovered from the 
surface of the microarray, PCR amplified, cloned, and sequenced.   The 
largest clone contained a ~1.1kb fragment that had 33% amino acid 
identity to a protein derived from murine hepatitis virus, a mouse 
coronavirus, thus confirming that the SARS-CoV was a novel virus.  The 
coalition of scientists collaborating on the SARS effort was then able to 
show that SARS-CoV specific antibodies could be detected in 
convalescent-phase serum from SARS patients and that SARS-CoV RNA 
could be detected in respiratory specimens. This strongly suggested that 
SARS-CoV was in fact the etiological agent of the SARS outbreak 
[40,43,44]. 
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 Identification of XMRV. The ViroChip has also been applied in the 
search for novel human tumor viruses, which lead to the 2007 discovery of 
a novel human retrovirus in a subset of prostate cancer patients carrying 
mutations in the RNase L gene [45].  Germline mutations in RNase L have 
been reported to confer an increased susceptibility to prostate cancer 
[29,46-48]. It was also known that such mutations were also linked with 
hereditary prostate cancer, which is defined by having 3 or more 
affected family members and is often recognized by the early onset of 
the disease[49]. However, there were conflicting reports based on case-
controlled studies regarding the involvement of the RNase L mutations in 
the development of prostate cancer. This suggested to some that there 
were perhaps other environmental or population differences that 
affected the contribution of RNase L mutations to prostate cancer 
susceptibility. Given that RNase L has a well established antiviral function, 
Urisman, et al. hypothesized whether the observed differences in 
susceptibility could be explained by the fact that mutations in RNase L 
actually led to a greater susceptibility to a viral agent [45]. RNA derived 
from biopsied prostate tumors with and with out mutations in RNase L was 
hybridized to the ViroChip. A distinct gammaretrovirus was identified that 
was detected in 8/20 (40%) tumors homozygous for the mutation in 
RNASEL, while retroviral sequences were only detected in 1/66 (1.5%) 
tumors bearing at least one wild-type allele. This virus appeared to be 
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most closely related to xenotropic murine leukemia virus lending itself to 
the name Xenotropic Murine-like Retrovirus (XMRV) and represented the 
first of its kind to be detected in humans. In situ hybridization of prostatic 
tumors with XMRV derived probes and immunohistochemistry probing for 
viral retroviral proteins showed the presence of the virus in the tumors 
suggesting there could be a link between XMRV infection and prostate 
cancer. Later work has shown that XMRV is integrated in some tumor cells 
and that replication of the virus is susceptible to RNase L [50].  It is currently 
unclear whether XMRV plays a causal role in prostate cancer or whether 
its presence is a secondary event.  
 
Identification of HTCV-UC1.   In an effort to identify novel respiratory 
pathogens, respiratory secretions collected from patients with influenza-
like symptoms were screened by conventional assays for respiratory 
syncytial virus, influenza virus, parainfluenza virus, adenovirus, and 
picornaviruses (rhinoviruses and enteroviruses). Samples that remained 
negative after all diagnostic testing were then analyzed with the ViroChip. 
One array had a hybridization pattern suggesting that a cardiovirus was 
present in the sample [20]. Conventional diagnostic testing panels for 
respiratory viruses do not include any members of the Cardiovirus genus in 
the family Picornaviridae.   Primers were designed from the highest 
intensity oligonucleotides and from alignments of conserved regions of 
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the known cardiovirus genomes in order to try and amplify portions of the 
cardiovirus present in the sample. The full sequence of this cardiovirus, 
HTCV-UC1, was then obtained. Testing of 428 respiratory specimens failed 
to identify additional cases. However, similar viruses were identified in 6 
out of  767 stool samples tested [20].  HTCV-UC1 appeared to be closely 
related to Saffold-like cardioviruses, which were initially discovered using 
the DNase-SISPA strategy [19,21,22]. These studies define a new group of 
cardioviruses which seemed to be the first human cardioviruses and have 
tropism for both the respiratory and gastrointestinal tract.  The role of these 
viruses in human disease remains to be determined.  
 
 Identification of animal viruses. Two final examples demonstrate the 
universality of pan-viral microarrays designed using all available viral 
sequences. By including sequences from all viruses without restrictions 
based on either viral taxonomy or putative host species, not only human 
samples but plant and animal specimens can be analyzed.   In one 
instance, the ViroChip was used to analyze liver tissue from a beluga 
whale that had died mysteriously in an animal park.   A strong 
hybridization signature from conserved coronavirus probes was observed 
on the ViroChip, which ultimately led to the identification and complete 
sequence of a highly divergent, novel coronavirus [51].   
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The ViroChip was also used in the discovery of an avian bornavirus 
found in samples derived from cases of a disease called proventricular 
dilation disease (PDD) [52]. PDD is an inflammatory disease affecting over 
50 species of parrots as well as other orders of birds.  It had been long 
thought that there was an infectious etiology for this disease and a 
number of viral agents had been implicated over the years. For example, 
electron microscopy analysis led some to believe that a paramyxovirus 
was responsible, but this was later ruled out [52]. Other reports came out 
reporting the culturing of an unidentified virus, but this virus was never 
identified [52].  ViroChip analysis of PDD cases versus controls suggested 
that a novel bornavirus, referred to as avian bornavirus (ABV), was present 
in 62.5% of the PDD samples and none of the controls (0/8). Mass 
sequencing (described in the next section) was used to obtain the full 
bornavirus genome from one of the samples. Further PCR screening of 
additional PDD samples revealed that the avian bornavirus was detected 
in 71% (5/7) of PDD cases and none (0/14) of the controls. Given the high 
correlation of ABV with PDD samples and not controls, it is highly 
suggestive that this virus could in fact be the etiologic agent of PDD. This 
case perfectly highlights the limitations of conventional approaches since 
for years the etiology of this disease was unknown and now the ViroChip 
has identified what could potentially be the causative agent of PDD.  
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 Pan-viral microarrays have proven to be successful tools for the 
detection of known viruses and the identification of multiple novel viruses.  
In conjunction with sequence independent PCR, microarrays offer a 
robust readout to define the nature of viruses present in a specimen.   
However, one key limitation of pan-viral microarrays is that highly 
divergent viruses that have little to no nucleotide similarity with known 
viruses will not be detected since the technology depends on cross-
hybridization between the unknown virus and probes derived from known 
viral genomes.    
 
DNA sequencing methods 
 Dideoxy sequencing or Sanger sequencing, first described in 1977 
[53], has been the dominant DNA sequencing technology used during the 
last ~30 years.  In the dideoxy sequencing process, primers designed to 
bind to a template of interest are added with dideoxynucleotides to a 
polymerase extension reaction.  Incorporation of a dideoxynucleotide 
prevents further extension of the primer-driven DNA synthesis reaction.  In 
the automated form of Sanger sequencing, each of the 4 
dideoxynucleotides is labeled with a distinct fluorescent dye. The 
truncated synthesis products are then run through a capillary containing a 
denaturing polymer that provides single base pair resolution separation. 
As each product passes through the end of the capillary it is excited by 
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light and the resulting fluorescence is recorded as one of four 
wavelengths, each corresponding to a different base. In this way, the 
sequence of the template can be deduced by determining which 
dideoxynucleotide was incorporated at each position of the 
complementary sequence. The typical sequence read length can reach 
750-800 bp.  This technology has been the cornerstone of all significant 
sequencing projects up to 2005, including the sequencing of the human 
genome.   Efficiencies gained in the monumental effort to sequence the 
human genome have enabled the production costs of Sanger 
sequencing in large genome sequencing centers to fall to as little as $0.35 
per read (as of this writing).       
Starting in 2005, multiple new sequencing technology platforms 
(“NextGen”) emerged that have far surpassed conventional Sanger 
sequencing in terms of increased total sequence production capacity 
and decreased cost.   While there are many NextGen platforms, in this 
review, we will limit our discussion to those that have been effectively 
utilized to date in the efforts to identify novel viruses.   These include 454 
pyrosequencing [54], commercially available in the form of the Roche FLX 
instrument and Solexa technology, which is marketed as the Illumina 
Genome Analyzer.  
454 pyrosequencing technology differs from Sanger sequencing in 
that natural nucleotides are used in the sequencing reaction.   Rather 
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than monitor the incorporation of nucleotides directly, successful 
incorporation of a nucleotide is inferred by measuring the quantity of 
inorganic phosphate (PPi) produced.  PPi is stoichiometrically converted 
to ATP, which provides energy for luciferase.  The quantity of light that is 
produced by luciferase as a given nucleotide is added to the reaction is 
indicative of the number of bases incorporated at that step.   By 
repeatedly adding dATP, dCTP, dGTP and dTTP into the reaction in series, 
up to 250 bp of contiguous sequence can be determined.   Another key 
feature of the 454 technology is that hundreds of thousands of these 
sequencing reactions are carried out simultaneously on independent 
beads.  This is accomplished by generating 1:1 DNA template:bead 
complexes.  First the target DNA to be sequenced is randomly sheared 
into fragments and then ligated to adapters.  Single stranded template 
DNA is isolated, mixed with the beads and then subject to emulsion PCR 
to clonally amplify the template on each bead.    Next, the beads are 
distributed into a fiber optically constructed plate (PicoTiterPlate) that 
contains millions of tiny wells.  Within each well that receives an individual 
bead, an isolated environment is created for the sequencing of each 
template, resulting in parallel sequencing of hundreds of thousand of 
templates at once. Currently, one 454 sequencing run produces ~400,000 
sequence reads of an average read length of ~250bp with imminent 
expansion of its capacity to ~1,000,000 reads of ~ 400 bp  [55].  
 - - 25 - - 
Solexa sequencing also uses a synthesis approach, but differs from 
454 pyrosequencing in a number of ways. Unlike the bead format of the 
454 platform, templates to be sequenced via Solexa sequencing are 
affixed to a solid surface. Adapter sequences are ligated onto the 
templates just as with 454, however, in Solexa sequencing these adapters 
not only serve as priming sites for PCR and sequencing, but they are also 
critical for the affixation of complementary templates to the solid surface 
through a mechanism called bridge amplification. The bridge 
amplification generates clusters of amplified template on the solid surface, 
where each cluster represents a different template. Solexa uses a unique 
chemistry that incorporates fluorescently labeled reversible terminator 
nucleotides in the sequencing reaction. The nucleotides are fluorescently 
labeled with different colors so that all four can be added to the reactions 
simultaneously. Due to the termination property of the nucleotides, only 
one individual nucleotide can be incorporated into each sequence 
during one sequencing cycle. The color of the fluorescent label 
incorporated into the sequences of each cluster is recorded and discerns 
which nucleotide was incorporated.  Removal of the terminator group on 
the nucleotide just added enables incorporation of the next 
complementary nucleotides and the cycle is repeated. The length of the 
read is dependent on the efficiency of removing the chain terminator 
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group at each step.  Currently, Solexa sequencing generates ~40-50 
million sequences of a read length of ~35bp [55]. 
To date, all three of these technologies, Sanger sequencing, 454 
sequencing and Solexa sequencing, have been used to characterize 
novel viruses. A schematic for generalized strategies of virus detection 
using mass sequencing are outlined in Figure 1.2.  
 
Sequence-independent amplification and sequencing strategies for virus 
detection 
Meyerson and colleagues conducted the first proof of principle 
experiment to demonstrate that extensive sequencing of nucleic acids in 
a specimen in conjunction with computational subtraction could be used 
to detect pathogens [56]. They examined a tissue specimen from a case 
of post-transplant lymphoproliferative disorder (PTLD), knowing that most 
cases of PTLD are caused by Epstein Barr virus (EBV). A cDNA library with 
27,840 sequences was generated and each individual sequence was 
compared to the human genome in order to identify those sequences of 
human origin.   These sequences were then eliminated from further 
consideration in a process termed “transcript filtering”.  The remaining 
sequences that did not match human genomic sequences were 
postulated to be derived from microbial organisms present in the sample.  
In fact, from this library, 10 sequences that did not match any human  
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Figure 1.2: Schematic of mass sequencing strategies for detection of known and novel 
viruses  
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sequences but had similarity to EBV were identified. Furthermore, these 
sequences could only be amplified from EBV infected tissues and not from 
controls, thus showing the potential power of mass sequencing strategies.   
 
 Identification of human bocavirus. The discovery of human 
bocavirus (HBoV) marked the 1st example of discovery of a novel virus by 
direct high throughput sequencing of clinical specimens (Figure 1.1B) [57]. 
In this study, pools of respiratory samples were ultracentrifuged, filtered, 
and DNase treated to produce samples for analysis that were highly 
enriched for intact viral particles (in which the genome is protected from 
DNase treatment) and to minimize the amount of other contaminating 
DNAs. In contrast to the discovery of human metapneumovirus, in which 
primers were arbitrarily chosen for amplification, a random PCR 
amplification strategy was used for amplification in the HBoV study. The 
amplified products were then cloned and ~300-500 clones were 
sequenced without any effort to identify specific amplicons.  In this 
analysis, 20% of the sequences showed similarity to viral sequences, the 
majority of which were derived from known viruses. However, some of the 
sequences had only limited similarity to viruses in the Parvovirdae family, 
and more specifically the genus Bocavirus. The respiratory samples that 
were initially pooled together for sequencing analysis were independently 
screened by PCR for the presence of the novel bocavirus of which two 
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tested positive. Further PCR screening of other pediatric respiratory 
specimens revealed that HBoV could be detected in 3.1% of the samples.   
The potential role of human bocavirus in respiratory disease and 
gastroenteritis has been investigated in numerous subsequent studies.   
These epidemiologic and seroepidemiologic analyses have determined 
incidence rates of bocavirus between 2.7-19% (in respiratory secretions) 
and seroprevalence rates of 94.7-98.3% in healthy adults [14]. As with 
human metapneumovirus, this high seroprevalence rate suggests that 
HBoV may be well established in humans and could be an important 
human pathogen.  
 
Identification of novel polyomaviruses. For 36 years following the 
culture based discovery of JC virus (JCV) and BK virus (BKV) in 1971, it was 
assumed that these were the only two human polyomaviruses.  That 
picture changed dramatically in a 12 month span in 2007-2008 as 3 novel 
human polyomaviruses were discovered, all by use of high throughput 
sequencing strategies.   In 2007, sequencing of randomly amplified 
products generated from clinical respiratory samples resulted in the 
detection of 2 novel polyomaviruses, KI polyomavirus (KIV) and WU 
polyomavirus (WUV) [58,59].  KIV was identified using the same 
experimental strategy that led to the discovery of human bocavirus [57].  
The discovery of WUV followed a parallel approach with the exception 
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that individual respiratory specimens rather than pooled specimens were 
analyzed. In both cases, sequences were identified with limited similarity 
(≤50%) at the amino acid level to the known primate polyomaviruses at 
the time.  
The full genomes of KIV and WUV were sequenced and analyzed. 
Phylogenetic analysis demonstrated that KIV and WUV were actually most 
similar to each other (~65-70% amino acid identity) and appeared to 
represent a new subclass of polyomaviruses.   Both of these viruses shared 
many similarities that distinguish them from JCV and BKV, including the 
lack of an Agno protein, the absence of a C-terminal extension domain of 
the Large T antigen, and altered origins of replication. In terms of tropism, 
neither WUV nor KIV have been detected to date in urine, in contrast to 
JCV and BKV which are both frequently detected in urine.  Both WUV and 
KIV have been found to be prevalent in the respiratory tract, with WUV 
having a prevalence of up to 7% in respiratory infections with KIV’s 
prevalence generally slightly lower [60-65]. They are often found as part of 
a co-infection with other viruses and have also been found in respiratory 
secretions of asymptomatic individuals, so the pathogenesis of these 
viruses is presently unclear.  Persistence of WUV in respiratory secretions of 
immunocompromised individuals has been described [66].  
A third novel polyomavirus was discovered in 2008 in human merkel 
cell carcinomas (MCC) [67].  Merkel cell carcinoma is an aggressive form 
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of skin cancer that has a 33% mortality rate which has been increasing in 
incidence in recent years [68].  The rationale for pursuing a potential 
infectious etiology for MCC lies in the increased susceptibility among 
immunosuppressed patients [69].  Feng et al. generated cDNA libraries 
from four MCC tumors and subjected them to high-throughput mass 
sequencing using 454 pyrosequencing. ~400,000 sequences were 
generated. Poor quality sequences and those that aligned to known 
human RNA, human chromosomes, mitochondria, or immunoglobulin 
sequences were removed from the final analysis. Of the remaining 2,395 
sequences, one sequence was detected which had limited similarity to a 
primate polyomavirus. The full genome of the polyomavirus represented 
by this sequence, referred to as Merkel cell polyomavirus (MCV), was 
subsequently sequenced.  Phylogenetic analysis determined that MCV 
was most closely related to African green monkey polyomaviruses and 
was only much more distantly related to JCV, BKV, WUV and KIV.  Upon 
screening 10 other MCC tumors by PCR and Southern blotting, it was 
found that 80% of them were positive for MCV, whereas only 5/59 control 
tissues were positive.   The virus was also found in 4/25 (16%) skin and non-
MCC skin tumors. A striking observation was that the MCV DNA was 
clonally integrated into the MCC tumors, indicating that MCV integration 
is an early event during the transformation process and thus may 
contribute to tumorigenesis.  Mechanistically, this may be the 
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consequence of the putative transforming ability of the MCV T-antigen or 
alternately it may be due to cellular alterations resulting from integration 
of the MCV genome, or a combination of the two. Follow up studies have 
generally corroborated the detection of MCV in the majority of Merkel 
tumor specimens [70-73].   If future studies definitively implicate MCV in the 
etiology of Merkel cell carcinoma, it would be the first clear cut example 
of a polyomavirus playing a role in human cancer, after many years of 
debate over the role of polyomaviruses in human cancer [74].  The 
discovery of Merkel polyomavirus was the first published report using 454 
sequencing to discovery a novel virus.  Of relevance for the continuing 
quest to identify potential infectious etiologies of human cancers, the fact 
that only 1 out of 400,000 sequence reads yielded a viral sequence 
suggests that as sequencing technologies continue to improve, it will be 
possible to detect viral nucleic acid sequences present at even lower 
abundances.   
The identification of 3 novel polyomaviruses within a 12 month span 
by use of similar high throughput sequencing strategies underscores both 
the promise of such strategies as well as the fact that the diversity of 
viruses that constitute the human virome is vastly underestimated. 
Moreover, the identification of a novel human polyomavirus that appears 
to be strongly associated with a human tumor greatly broadens our 
paradigms of polyomaviruses.   As the application of mass sequencing 
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strategies gain favor, we anticipate that most viral families will gain new 
members that may similarly broaden our understanding of those virus 
families.  Even more tantalizing is the possibility that completely novel 
families of viruses may be identified through the use of such approaches.  
 
Detection of an arenavirus in a fatal transplant cluster. Another 
example of the utility of 454 pyrosequencing in detecting viruses comes 
from identification of an arenavirus associated with a cluster of fatal 
transplant-associated diseases [75]. Cerebrospinal fluid, serum, and tissue 
samples from two individuals who died 4-6 weeks after receiving organ 
transplants from the same donor were sequenced.  14 fragments out of 
94,043 sequence reads had sequence similarity to LCMV.  The results of 
this analysis suggested the specimens contained an arenavirus, which was 
then isolated in tissue culture from an infected kidney homogenate. 
Serum antibodies of both individuals reacted with the viral culture and 
were used to show immunostaining of viral antigens in the tissue 
specimens. While significant debate over whether this virus is indeed novel 
is ongoing [76], this case nonetheless illustrates two important points: (1) 
high throughput sequencing is a robust methodology for detection of 
viruses both known and novel; (2) as strictly sequence based methods 
gain prominence, viral taxonomy needs to be restructured to 
accommodate sequence based classification. 
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Avian bornavirus sequencing. The initial discovery of a novel avian 
bornavirus (as discussed previously)  was based upon hybridization of 
specimens to a pan-viral microarray [52].  In order to sequence the 
complete genome of the avian bornavirus, Kistler et al. utilized Solexa 
sequencing technology.  A total of 1.4 million 33 bp reads were obtained 
from specimens positive for the virus. The sequences were filtered for read 
quality, sequence complexity, and the presence of inserts which reduced 
the number of usable reads to 600,000. Host sequences, approximately 
50% of all the reads, were computationally subtracted from this pool by 
comparison to sequences of all available avian species.  Comparison of 
the remaining sequence reads to all Borna Disease virus sequences 
identified 1,400 sequences that appeared to be derived from this novel 
virus.  Conventional PCR-based methods were required to fill in the gaps 
of the genome where no sequences were identified in the mass 
sequencing. Retrospective analysis once the full genome of the avian 
bornavirus was obtained showed that there were twice as many 
sequences derived from the virus than initially identified. In total, 
sequences from the virus constituted 1% of all the sequence reads.   This 
study was the first to use Solexa technology for de novo sequencing of a 
novel virus genome.     
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Identification of seal picornavirus. As demonstrated with some of 
the other methods, mass sequencing is not limited to the analysis of 
human samples.  Application of mass sequencing to the supernatant of 
cells inoculated with a nasal swab from a seal yielded sequences that 
had 22-41% amino acid identity to known picornaviruses [77]. The degree 
of divergence of this virus, called seal picornavirus 1 (SePV-1), to other 
picornaviruses suggests that this virus might represent a new genus in the 
family Picornaviridae.  Moreover, this is the first example of a picornavirus 
infecting a marine mammal, which again underscores our relative 
ignorance regarding the diversity of viruses that surround us. 
 
 Mass sequencing of human stool. Recently, high throughput 
sequencing has been applied to the analysis of human stool samples 
collected from healthy individuals [78,79].  Sequences from phage and 
plant viruses were dominant in the analysis of healthy stools. However, the 
question: “What is viral content of diarrheal stools?” remained a major 
question. Specifically, I wanted to know what viruses could be found in 
diarrheal stools, if I could find novel viruses, and if I found novel viruses, 
might they be linked to diarrhea or some other human disease?  It 
therefore became my interest to apply cutting edge technologies like 
mass sequencing to examine which viruses are present in diarrhea 
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specimens and to search for novel viruses potentially associated with 
diarrhea.   
 
Impact of diarrheal disease 
Diarrhea is estimated to be the third leading cause of death due to an 
infectious disease [80]. While data from socioeconomically developing 
countries is sparse, mathematical modeling based on the data that is 
available suggests that ~2 - 2.5 million children under the age of 5 die 
every year from diarrhea. The overall disease burden is much greater with 
an estimated 1.4 billion episodes of diarrhea occurring each year in 
developing countries and 9 million of these episodes requiring 
hospitalization [81]. In developing countries, conditions such as poor 
sanitation, malnutrition, poor healthcare, and the rising rates of HIV 
infections in many regions all contribute to the burden of diarrheal disease 
[81,82]. In developed countries, mortality rates have been drastically 
reduced by the use of oral rehydration therapy as a treatment for 
diarrhea. Despite this, there are still an estimated 211-375 million episodes 
of acute diarrhea that occur each year in the United States, with 1.8 
million episodes resulting in hospital admissions [83]. 
 There are over 20 known enteropathogens which include bacteria, 
viruses and parasites. A small percentage of the annual cases of diarrhea 
are attributable to parasite infections with most occurring in developing 
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countries. Viruses are responsible for causing the greatest number of  the 
annual cases of diarrhea, while bacteria are responsible for a significant 
portion of the cases, but still less than those caused by viruses [84-86]. 
Rotaviruses, astroviruses, caliciviruses, and adenoviruses are the major 
causes of viral diarrhea [87,88]. These viruses were all identified as 
etiologic agents of diarrhea in the 1970s [89-92]. While there are other 
viruses that have been suggested to be linked to diarrhea, there have 
been no major discoveries of new enteric viruses since the initial 
identification of the four major viral diarrhea pathogens [87,88]. This 
becomes important in light of the fact that ~20-40% of cases of acute 
sporadic diarrhea are caused by unknown etiology [93]. Likewise, it is 
estimated that up to ~12-40% of gastroenteritis outbreaks are also of 
unknown etiology even after extensive testing, suggesting that there is a 
diagnostic gap [94,95]. In the United States alone, it is estimated that there 
are 5,000 yearly deaths which occur as a result of gastroenteritis of 
unknown etiology (GUE), accounting for 77% of the deaths in U.S. caused 
by diarrhea [96]. Given that viruses play such a large role in the disease 
burden of diarrhea, that no new viral cause of diarrhea has been 
discovered in the last 30 years,  and given that a number of viruses have 
been described morphologically upon observation of their presence in 
loose stools but not characterized further, there is good reason to believe 
 - - 38 - - 
that there are other viral agents of diarrhea that have yet to be 
discovered [97-99].   
 Mass sequencing of pediatric diarrhea samples which were 
determined to be negative for known enteric agents by conventional 
assays such as PCR and enzyme immunoassays was carried and is 
described in Chapter 2. Use of this methodology in screening of acute 
sporadic diarrhea samples resulted in the identification of a novel 
astrovirus which will be referred to as Astrovirus MLB1 (AstV-MLB1), and 
which is described in Chapters 2-4. In addition, the use of mass 
sequencing to analyze diarrhea samples from a gastroenteritis outbreak 
resulted in the identification of an additional novel astrovirus referred to as 
Astrovirus VA1 (AstV-VA1), which is described in Chapter 5. 
 Astroviruses were first described in 1975 by electron microscopic 
examination of fecal extracts [100,101]. Since this first discovery, 
astroviruses infecting cattle, sheep, cats, dogs, deer, chickens, turkeys, 
ducks, and bats have also been described in addition to the eight human 
serotypes that have been identified [102,103]. The human astroviruses 
most frequently cause diarrhea in children under the age of 2, the elderly, 
and immunocompromised individuals [104]. Typical symptoms are watery 
diarrhea, while vomiting, headache, fever, abdominal pains, and 
anorexia occurring to a lesser extent. Symptoms usually last 2-4 days. 
Astroviruses account for 10% of sporadic cases of non-bacterial diarrhea 
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and the magnitude of their impact on disease burden seems to be 
increasing with the development of more sensitive technologies for 
astrovirus detection and increased surveillance [105].   
The name astrovirus comes from the observation that ~10% of the 28 
nm particles have a star like morphology. Astroviruses are non-enveloped, 
single stranded, positive sense RNA viruses. The genomes, which range 
from 6.4 kb to 7.9 kb in length, are polyadenylated, contain 3 open 
reading frames (ORFs 1a, 1b, and 2), and have both 5’ and 3’ 
untranslated regions (Figure 1.3). Their genomic organization, which is 
similar to that of caliciviruses, is:  (from 5’ to 3’) ORF 1a, which encodes a 
serine protease; ORF1b, which encodes the RNA dependent polymerase; 
and ORF 2, which encodes the structural proteins. A frameshift must occur 
during the translation of ORF 1a in order for ORF 1b to be translated. ORF 2, 
on the other hand, is translated from a sub-genomic RNA and produces a 
polyprotein which is cleaved by cellular proteases [106].  
 
 
Figure 1.3: Schematic of genomic organization of astroviruses. Sizes of the open reading 
frames correspond to those of Human Astrovirus 1. 
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This dissertation manuscript describes work that was done to first 
identify which viruses can be found in diarrhea samples and which then 
led to the discovery of multiple novel astroviruses (AstV-MLB1 and AstV-
VA1). The remaining body of this manuscript describes the efforts to further 
characterize these newly discovered astroviruses and to begin answering 
important questions raised by their discoveries. Characterization of these 
viruses may reveal that astroviruses contribute more to the global disease 
burden of gastroenteritis than previously recognized. Furthermore, the 
discovery of two novel astroviruses in such a short time frame indicates 
that there may be more astroviruses waiting to be discovered and that 
perhaps more energy should be devoted to studying astroviruses since 
the work described herein only begins to scratch the surface in terms of 
our understanding of astrovirus biology.  
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Metagenomic Analysis of Human Diarrhea:  
Viral Detection and Discovery 
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ABSTRACT 
Worldwide, approximately 1.8 million children die from diarrhea annually, 
and millions more suffer multiple episodes of nonfatal diarrhea.   On 
average, in up to 40% of cases, no etiologic agent can be identified.  The 
advent of metagenomic sequencing has enabled systematic and 
unbiased characterization of microbial populations; thus, metagenomic 
approaches have the potential to define the spectrum of viruses, 
including novel viruses, present in stool during episodes of acute diarrhea.  
The detection of novel or unexpected viruses would then enable 
investigations to assess whether these agents play a causal role in human 
diarrhea.  In this study, we characterized the eukaryotic viral communities 
present in diarrhea specimens from 12 children by employing a strategy of 
‘micro-mass sequencing’ that entails minimal starting sample quantity 
(<100 mg stool), minimal sample purification and limited sequencing (384 
reads per sample).  Using this methodology we detected known enteric 
viruses as well as multiple sequences from putatively novel viruses with only 
limited sequence similarity to viruses in Genbank.  
 
 
INTRODUCTION 
 While traditional sequencing approaches are designed to 
characterize genomes of a single species of interest, metagenomic 
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approaches, such as mass sequencing, transcend species boundaries 
allowing one to explore the makeup of microbial communities. Such 
methods provide a holistic look at microbial diversity within a given 
sample, completely bypassing the need for culturing [107-111]. Previous 
efforts in this field have explored the structure of virus communities in 
ecosystems as diverse as the ocean [107,112] and the human gut [78,79].  
To date, the reported metagenomic studies of human stool have been 
limited to analysis of 4 specimens collected from 3 healthy patients [78,79].  
To our knowledge, no metagenomic investigation of the viral diversity 
found in human diarrhea has previously been described.  Human diarrhea 
is the third leading cause of infectious deaths worldwide and is responsible 
for ~ 1.8 million deaths in children under age five each year [80].  Bacteria, 
protozoa and viruses have all been implicated as causal agents.  Chief 
among the known etiologic agents are rotaviruses, noroviruses, 
astroviruses, and adenoviruses [113]  However, it is estimated that on 
average up to 40% of diarrhea cases are of unknown etiology, suggesting 
that unrecognized infectious agents, including viruses, remain to be 
discovered [85,93,114-116].  Mass sequencing affords an opportunity to 
explore the viral diversity (including both known and novel viruses) present 
in stool during acute episodes of diarrhea in a systematic and unbiased 
fashion, thereby laying the foundation for future studies aimed at 
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assessing whether any novel or unexpected viruses detected play a 
causal role in human diarrhea.   
In this study, mass sequencing was applied to explore specifically 
the viral communities present in pediatric patients suffering from diarrhea.  
We anticipated that the viral communities would vary significantly from 
specimen to specimen and that it would be desirable to sample broadly 
from multiple patients to obtain an overall perspective on the diversity of 
viruses that might be present.   Toward this end, a simple yet robust 
experimental strategy was developed that circumvented certain 
technical and economic limitations of conventional mass sequencing.  In 
both previous viral metagenomic studies of the human gut, large 
quantities of fecal matter (~500g) were collected from adults and then 
extensively purified to enrich for viral particles [78,79].  In contrast, 
pediatric samples provide considerably smaller volumes of stool; therefore, 
our strategy was designed to minimize the number of physical purification 
steps so that as little as 30 mg of archived fecal matter could be analyzed.  
Here we present data generated by performing what we refer to as 
‘micro-mass sequencing’ of several hundred sequence reads per sample 
from 12 different patients with acute diarrhea.  This analysis provides 
evidence for the detection of known enteric viruses, viral co-infections, 
and novel viruses.   
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RESULTS 
Aggregate library analysis.  Metagenomic analysis was carried out 
on fecal samples collected from 12 distinct pediatric patients suffering 
from acute diarrhea. Patient characteristics are shown in Table 2.1. A 
sequence independent PCR strategy was employed to amplify the 
extracted nucleic acids from each sample [41]. 384 clones were 
sequenced for each sample library. Because the goal of this project was 
to define the diversity of viruses present in the clinical specimens 
regardless of their relative abundance, nearly identical sequence reads 
were clustered to generate a set of non-redundant sequence reads. 
Unique, high quality sequence reads were then classified into broad 
taxonomic groups based on the taxonomy of the most frequent top 
scoring BLAST matches for each sequence. A total of 4,608 sequences 
were generated, of which 3,169 passed through a quality filter and 2,013 
of those contained unique sequence information. Of the unique 
sequences passing through the filter, 1,457 (72%) could be identified by 
similarity to sequences in the Genbank nr database based on tBLASTx (E-
value ≤10-5) alignments. The remaining 556 (28%) sequences had no 
significant similarity to any sequences in the nr database and were  
therefore categorized as being of ‘unknown’ origin. The 1,457 identifiable 
sequences were further classified into categories based on their proposed 
origin (Figure  2.1). 519 (35.6%) were most similar to eukaryotic viruses, 25 
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Table 2.1: Sample Information. 
Sample 
Year 
Collected Age of Patient 
# of high quality 
sequence reads 
# of 
unique 
reads 
Average 
unique read 
length (bp) 
D01 2005 14 mo 365 166 526 
D02 1998 10 mo 348 104 499 
D03 1984 NA 302 281 506 
D04 1984 4 mo 311 154 626 
D05 1980 NA 243 168 563 
D06 2003 11 mo 153 132 393 
D07 1999 23 mo 352 186 617 
D08 1999 35 mo 302 167 255 
D09 1981 NA 302 294 491 
D10 1983 20 mo 195 146 447 
D11 1978 NA 253 103 367 
D12 2005 8 mo 198 129 300 
 
 (1.7%) to phage, 857 (58.8%) to bacteria, 3 (0.2%) to fungi, and 20 (1.4%) 
to human sequences.  The remaining 33 (2.3%) were most similar to 
sequences that did not fall into the other previous categories and were 
consequently labeled as ‘other’. For example, some of the sequences 
had significant hits to mouse, fish, and plant genomes. 
Individual library statistics. 384 clones were sequenced for each 
individual sample. The proportion of high quality sequences for each 
sample varied between 40% and 95% of the total clones (Table 2.1). The 
percentages of unique sequences per sample ranged from 41% to 97% of 
the high quality reads (Table 2.1). The average length of the unique, high 
quality sequences ranged from 255 to 626 bp. Viral sequences constituted  
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Figure 2.1: Composite analysis of all 
sequences 
Sequences from all 12 libraries were 
categorized based on the best 
tBLASTX scores (E-value: <10-5) as 
viral, phage, bacterial, human, 
fungal, other, or unassigned. 
Numbers in parenthesis represent 
the number of sequences in each 
category.  
 
 
 
between 0-100% of the reads in each library (Figure 2.2). Some libraries 
(e.g., D01 and D05) were predominantly composed of viral sequences 
(64% and 95% respectively), whereas others consisted largely of bacterial 
(e.g., D08 and D12) or unassigned (e.g., D03 and D07) sequences. Based 
on the initial BLAST classification criteria, sequences with similarity to viruses 
from 7 different viral families and three unclassified genera (picobirnavirus, 
anellovirus and mimivirus) were detected in the 12 different samples (Fig. 
2.2).  Five of the samples (D03, D05, D06, D08, and D12) contained 
sequences from at least two different virus families known to infect 
humans. 
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Figure 2.2: Categorization of sequence reads based on best tBLASTX scores  
(E-value: <10-5)  
Pies on the left side of each box depict the categorization of sequences from individual 
samples by phylotype: viral (V); phage (P); bacterial (B); human (H); fungal (F); other (O); 
and unassigned (U). Pies on the right side of each box depict further characterization of 
viral sequences by viral families/taxa: Reoviridae (Reo); Caliciviridae (Calici); Astroviridae 
(Astro); anellovirus (Anello); picobirnavirus (Picobirna); Picornaviridae (Picorna); mimivirus 
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(Mimi); Nodaviridae (Noda); Adenoviridae (Adeno); Parvoviridae (Parvo). Numbers in 
parentheses indicate the number of sequence reads in each category. 
 
Detection of known viruses.  The first specimen analyzed was a 
positive control stool specimen that had tested positive for rotavirus (D01) 
by enzyme immunoassay.  It was our expectation that this sample would  
yield sequences derived from the infecting rotavirus. In this library, 107 
non-redundant sequence reads were identified as viral in origin, almost all 
of which possessed ≥ 90% amino acid (aa) BLAST identity to known 
rotavirus sequences in Genbank. The sequence data included cloned 
fragments from all 11 RNA segments of the rotavirus genome.  
An additional 11 stool specimens were then selected that had 
tested negative in conventional PCR and enzyme immunoassays for the 
known diarrhea viruses (rotaviruses, caliciviruses, astroviruses, and 
adenoviruses). Despite such screening, sequences derived from the 
canonical enteric viruses were detected in a number of samples.  For 
example, calicivirus sequences were detected in D02 and D06, astrovirus 
sequences in D04, and adenoviruses were detected in D05 and D12. 
Almost all individual sequence reads in these cases possessed >90% aa 
identity to existing viral sequences in Genbank. 
Adeno-associated virus (AAV), a member of the Parvoviridae family, 
was detected in two samples, D11 and D12. These viruses are known to 
infect the gastrointestinal tract, but are not thought to be enteric 
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pathogens. For productive infections or reactivation from a latent state, 
AAV requires co-infection with a helper virus that is most commonly an 
adenovirus or less typically, a herpesvirus [117]. In D12, adenovirus 
sequences were detected. No additional viruses were detected in D11. 
Detection of novel virus sequences.  In many of the libraries, 
individual sequence reads were detected that possessed ≤ 90% aa 
identity to their highest scoring BLAST hit (representative sequences are 
listed in Table 2.2) suggesting that these sequences might be derived from 
novel viruses.  In part because BLAST alignments are based on local 
sequence comparisons, BLAST is not an optimal method for making 
taxonomic assignments.  In order to more accurately and precisely assess 
the relationship of these sequences to known viruses, we generated 
phylogenetic trees using the maximum parsimony method [118]. In cases 
where more than one sequence read hit the same region of a genome, 
only one representative sequence read is listed in Table 2.2 and 
phylogenetic trees are shown for only these representative sequences (Fig. 
2.3, 2.4 and Fig. 2.S1-S4). Phylogenetic analysis revealed that many of the  
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Table 2.2: Selected sequence reads with limited BLAST identity to known viruses 
Sample 
Sequence 
Read 
Accession 
# Identity to top hit 
Top Hit 
(Accession #) Virus Family/Taxa 
D03 ET065742 78% 
Human 
picobirnavirus 
strain 1-CHN-97 
(AF246939) 
Picobirnavirus 
D03 ET065743 90% 
Human 
coxsackievirus A19 
(AF499641) 
Picornaviridae 
D06 ET067042 74% 
Human enterovirus 
91 (AY697476) 
Picornaviridae 
D06 ET067045 66% 
TTV-like mini virus 
(AB026931) 
Anellovirus 
D06 ET067040 79% 
Snow Mountain 
virus (AY134748.1) 
Caliciviridae 
D06 ET067041 88% 
Norovirus C14 
(AY845056.1) 
Caliciviridae 
D08 ET065575 57% 
Human astrovirus 4 
(AY720891) 
Astroviridae 
D08 ET065582 67% 
Human astrovirus 5 
(DQ028633) 
Astroviridae 
D08 ET065578 45% TT virus (AB041963) Anellovirus 
D09 ET066010 35% 
Epinephelus 
septemfasciatus 
nervous necrosis 
virus (AM085331) 
Nodaviridae 
D10 ET066456 81% 
Human 
picobirnavirus 2-
GA-91 (AF245701) 
Picobirnavirus 
 
sequences were divergent from known sequences on the order that 
approximated a distinct subtype or genotype (Figures 2.S1-S4).  This 
included two libraries with picobirnaviruses (D03, D10) (Figures 2.S1), two 
with picornaviruses (D03, D06) (Figures 2.S2), two with anelloviruses (D06, 
D08) (Figure 2.S3), and one with a norovirus (D06) (Fig. 2.S4). 
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Figure 2.3: Phylogenetic analysis of highly divergent astrovirus-like sequence reads. 
Maximum parsimony phylogenetic trees were generated by comparing the translated 
amino acid sequence of individual sequence reads to the corresponding sequences 
from known astroviruses.  1,000 replicates were generated with bootstrap values over 700 
shown. A) Representative sequence read mapping to astrovirus serine protease ORF 
(Accession number ET065575); B) Representative sequence read mapping to astrovirus 
RNA polymerase (Accession number ET065582). 
 
In several instances, much more highly divergent sequences were 
detected that suggested that novel virus species might be present.   The 
library generated for sample D08 included 7 unique sequence reads 
derived from two loci that displayed 52-67% aa identity to human 
astroviruses. Phylogenetic analysis of the individual sequence reads 
suggested that a novel astrovirus was present in D08 (Figure 2.3).  These 
sequence reads were assembled into two contigs, one of ~800 bp that 
mapped to ORF1a and one of ~500 bp that mapped to ORF1b.  RT-PCR 
and subsequent sequencing of the amplicon confirmed the presence of 
the contigs in the original RNA extract as well as the contig assemblies 
(data not shown). Phylogenetic analysis of the two contigs yielded trees 
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essentially identical to those generated from the individual sequence 
reads (data not shown).   
In sample D09, we detected one sequence read which exhibited 
limited similarity to viruses in the family Nodaviridae (Table 2.2). RT-PCR of 
this sample using primers designed from the sequence read confirmed the 
presence of a 229 bp fragment in the original RNA extract (data not 
shown). Phylogenetic analysis of the sequence of the RT-PCR product 
demonstrated that the nodavirus in sample D09 was highly divergent from 
other known nodaviruses (Figure 2.4). 
 
Figure 2.4: Phylogenetic analysis of a highly divergent nodavirus-like sequence read. 
Maximum parsimony phylogenetic trees were generated by comparing the translated 
amino acid sequence of one sequence read (Accession number ET066010) to the 
corresponding RNA polymerase sequences of nodaviruses. 1,000 replicates were 
generated with bootstrap values over 700 shown. 
 
 
Finally, one sample, D03, contained five sequence reads that, 
based on the top tBLASTX hits, contained 47% to 52% aa identity to 
endonuclease genes in the amoeba-infecting virus Acanthamoeba 
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polyphaga mimivirus. These sequences also possessed approximately 
similar levels of sequence identity to a number of bacterial genomes and 
phage genomes containing putative endonuclease proteins. 
Phylogenetic analysis comparing the sequence reads to the top scoring 
BLAST hits (Figure 2.S5) did not conclusively clarify the origin of these 
sequences. Further experimentation will be required to unambiguously 
determine if these sequences are derived from a mimi-like virus, phage, or 
a bacterial species. 
Unassigned sequences. Some sequences in the libraries had no 
significant hits to any sequences in the Genbank nr database. Samples 
D03 and D07 had a large abundance of these ‘unassigned’ reads. 
Relaxing E-value thresholds for designating various sequence categories 
resulted in the ability to classify a greater number of these unassigned 
sequences; however, many of these classifications likely represent 
artifactual alignments. Viral assignments remained largely unaffected, 
even when E-value thresholds as permissive as 10 were applied. 
 
DISCUSSION  
We examined the diversity of viral communities in stools from 12 
children with diarrhea using a strategy we describe as ‘micro-mass 
sequencing’.  This strategy, which entails crude purification of fecal 
suspensions, nucleic acid purification, random PCR amplification, and 
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cloning and sequencing of several hundred colonies, effectively 
detected known enteric viruses, viral co-infections, and novel viruses.  In 
most traditional metagenomic studies, large sample volumes are 
subjected to multiple stages of filtration and purification before 
sequencing. For example, in previous metagenomic studies of the gut, 
500g of fecal samples were initially collected for the analyses. Because 
clinical pediatric diarrhea specimens are much more limited in volume, 
we chose to both minimally purify the samples and to employ a random 
PCR amplification strategy.  These combined steps enabled us to rapidly 
generate sequencing libraries from small quantities of archived stools (30-
100 mg).  Furthermore, we wished to sample broadly from multiple 
patients because of the large number of viruses known or suspected to be 
associated with diarrhea.  Therefore, rather than sequence few specimens 
in great depth as has been done previously (10,000 sequences per 
sample) [78], we focused on sequencing fewer clones (384 per sample) 
from more samples (12 specimens).  
Our analysis detected viruses, bacteria, host, phage and other 
sequences (Figures 2.1 and 2.2).  The presence of non-viral sequences in 
the libraries was not surprising as only minimal efforts were made to enrich 
for viral sequences.  In fact, the goal of this strategy was to manipulate 
the specimens as little as possible in the interest of simplicity.  Even so, in a 
few libraries, 100% of the sequence reads were of viral origin.   Additional 
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processing, such as treating the specimens with DNase, reduced the 
background signal and increased the percentage of viral reads in some 
instances (data not shown).  
Viral sequences were detected in all but one sample. Interestingly, 
a number of DNA viruses (bacteriophages, adenoviruses, and adeno-
associated viruses) were detected in our analysis, despite our use of a 
methodology focused on purification of RNA.  While it is possible that RNA 
transcripts from these viruses were purified [119], it is more likely that viral 
DNA was co-purified with RNA, as is common in other RNA purification 
methods [120]. PCR analysis of samples D05 and D11 in the absence of 
reverse transcription, yielded positive results for adenovirus and adeno-
associated virus, respectively, indicating that viral DNA was present in the 
RNA preparations (data not shown).  
Analysis of this initial cohort of 12 specimens yielded a wealth of 
original findings. In contrast to previous metagenomic studies of stool [78], 
a number of known human viruses were detected in these clinical 
specimens. These included common enteric pathogens such as rotavirus, 
adenovirus, calicivirus, and astrovirus.  In addition, putatively benign 
adeno-associated viruses (AAV) were also detected which are not 
generally associated with human diarrhea. Aside from one sample known 
to contain rotavirus, we intended to analyze the viral communities present 
in samples that were not infected by known enteric pathogens in order to 
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identify viruses that might be responsible for the unexplained cases of 
diarrhea. The fact that micro-mass sequencing detected these canonical 
viruses in some of the specimens, despite conventional diagnostic testing 
by EIA and PCR, underscores the sensitivity limits of conventional 
diagnostics.  
Detection of novel viruses.  Sequences were detected in this study 
from at least 9 putatively novel viruses.   For 7 of these sequences, the 
degree of divergence observed based on phylogenetic analysis 
suggested that they might represent novel virus subtypes or genotypes of 
picobirnavirus, enterovirus, TT virus and norovirus (Figures 2.S1-S4).  
Picobirnaviruses belong to an unclassified genus of double stranded RNA 
viruses and have been detected in fecal matter from human and other 
animals both with and without diarrhea [121]. Only a limited number of 
picobirnavirus sequences have been previously described in the literature 
and thus the identification of two novel picobirnaviruses significantly 
expands the known diversity of this taxonomic group, underscoring the 
unrecognized viral diversity inhabiting the human body.   
Sequences representing a divergent norovirus were detected in 
sample D06 (Figure 2.S4).   Phylogenetic analysis of individual sequence 
reads that mapped to the RNA polymerase and the NS4 regions of human 
norovirus suggested that these sequences were derived from a novel or 
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unsequenced member of norovirus genogroup 2.  In the initial screening 
by conventional PCR, this sample tested negative for norovirus. Upon  
closer examination, four mutations were observed in one of the PCR 
primer binding sites, which plausibly hindered the PCR screening assay 
[85].   
In two samples, much more highly divergent sequences were 
detected.  In D08, phylogenetic analysis of 7 unique sequence reads 
strongly suggested that a novel astrovirus species was present (Figure 2.3).  
The observed sequence variation between these sequence reads and 
the known astrovirus genomes greatly exceeds the variation that exists 
between the 8 known serotypes of human astrovirus, suggesting that this 
virus is not simply another serotype of the known astroviruses.  Astroviruses 
are non-enveloped, single stranded, positive sense RNA viruses that 
account for up to 10% of sporadic diarrhea cases [105]. Infections with 
astroviruses most frequently cause watery diarrhea lasting 2-4 days, and, 
less commonly vomiting, headache, fever, abdominal pain, and anorexia 
in children under the age of 2, the elderly, and immunocompromised 
individuals [104].  The detection of this genetically distinct astrovirus raises 
the question as to whether or not this is an authentic human virus, and if so, 
whether or not it is a causal agent of human diarrhea.    
Another novel sequence detected appeared by phylogenetic 
analysis to belong to the family Nodaviridae (Figure 2.4).   Nodaviruses are 
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small single-stranded, positive sense, bipartite RNA viruses, divided into 
two genera, the alphanodaviruses (insect viruses) and the 
betanodaviruses (fish viruses). Currently, none of the established family 
members are known to naturally infect mammals although experimental 
manipulation of the viral genome has enabled viral replication in a wide 
array of organisms including mammals [122].  While it is tempting to 
speculate that this might represent the first instance of human infection 
with a nodavirus, further experimentation such as serological analysis is 
required to definitively answer this question.  Another plausible 
explanation is that the virus may be present simply as a result of 
consumption of fish infected by the virus. A prior report describing the 
presence of plant virus RNAs in human stool has similarly been attributed 
to dietary exposure [78].  Incidentally, some fish genomic sequences were 
detected in this particular sequence library (D09 “other” bin) supporting 
the possibility of dietary exposure.  However, the potential piscine origin of 
this virus would not necessarily preclude its role as an etiologic agent of 
human disease.  
The micro-mass sequencing approach, like any other experimental 
methodology capable of detecting novel viruses (such as culture or 
degenerate PCR), cannot of course by itself determine whether the newly 
detected agent is pathogenic.  However, this strategy can generate 
novel, testable hypotheses such as “Are these novel viruses involved in the 
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etiology of human diarrhea?” and “What is the true host of these viruses?” 
that could not be asked in the absence of the knowledge that these 
viruses existed.  
Unassigned reads.  556 out of the 2013 (28%) unique high quality 
sequences were binned as unassigned by the BLAST criteria.  Of these, 23 
were identified as containing repetitive elements or low-complexity 
sequence by RepeatMasker [123,124] thus explaining the lack of 
meaningful BLAST alignments.  The origin of the remaining 533 sequences 
that were unassigned is uncertain, but they could be derived from 
unannotated host genome, novel or unsequenced microbes, or dietary 
sources which have not been sequenced. However, it is also possible that 
some of these sequences could represent viruses that have no 
appreciable similarity to sequences of currently known viruses.  Extracting 
more telling information from these sequences is a challenging problem 
that will require the development of new computational measures 
capable of detecting more distant evolutionary relationships than is 
possible with existing methods.  In addition, as more genome sequences 
from diverse organisms and other genomic/metagenomic projects 
become available, sequence similarity based methods may identify a 
greater fraction of these currently unassigned sequences. 
Diagnostic Applications and Implications. Our data suggest that 
micro-mass sequencing might be of great diagnostic utility for a number 
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of reasons. First, viruses escaping detection in conventional assays were 
detected by micro-mass sequencing. In theory, the sensitivity of this 
strategy is limited only by the depth of sequencing. As demonstrated here, 
even shallow sequencing performed better than conventional diagnostics 
in some instances.  In addition, the unbiased nature of the method 
enabled detection of viruses not conventionally tested for.  Moreover, co-
infections were detected in multiple samples. Furthermore, for multi-
segmented viruses such as rotaviruses, reassortment of segments between 
species is a major mechanism of viral evolution that can lead to the 
emergence of more virulent strains [125].  Complete genome sequencing 
of all segments simultaneously would yield completely unambiguous 
identification of the viral genotype.  In contrast to typical PCR or antibody 
based assays that target a single segment or protein, micro mass 
sequencing detected all 11 genomic RNA segments of rotavirus. In terms 
of technical practicality, samples were only minimally manipulated 
relative to traditional metagenomic sequencing [78,107,109,112], thereby 
avoiding the time, labor, and use of specialized equipment required to 
concentrate the specimens, rendering this methodology potentially 
amenable to use in diagnostic laboratories. As sequencing costs diminish 
and efficiencies improve, mass sequencing could become a powerful 
diagnostic tool. 
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In summary, we have shown that micro-mass sequencing can 
define the diversity of viral communities found in fecal samples from 
diarrhea patients.  Both known viruses and novel viruses were detected by 
sequencing only a few hundred colonies from each sample library.  These 
studies will serve as the springboard for further interrogations of the roles of 
these diverse viruses in the gastrointestinal tract.   Finally, our detection of 
multiple novel viruses in this initial, limited exploration of a dozen samples 
suggests that broader sampling of patient specimens is likely to be highly 
fruitful in terms of identification of additional novel viruses. 
 
MATERIALS AND METHODS 
Clinical Archived Stool Specimens.  
Melbourne Cohort. Stool samples were collected from children under the 
age of 5 who were admitted to the Royal Children’s Hospital, Melbourne, 
Victoria, Australia with acute diarrhea between 1978 and 1999.  
 
Seattle Cohort. Stool samples were collected between 2003-2005 at the 
Emergency Department of the Children’s Hospital and Regional Medical 
Center in Seattle, Washington, USA as part of a prospective study 
attempting to discern the cause of unexplained pediatric diarrhea. 
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Diagnostic testing of stool specimens for known microbial diarrheagenic 
agents. 
Melbourne Cohort. Specimens were tested by routine enzyme 
immunoassays (EIA) and culture assays for rotaviruses, adenoviruses, and 
common bacterial and parasitic pathogens as previously described [85]. 
RT-PCR assays were used to screen specimens for the presence of 
caliciviruses and astroviruses [85,126] .  
 
Seattle Cohort. Specimens were tested for the presence of a number of 
bacterial species (Campylobacter jejuni, Escherichia coli O157:H7 and 
non-O157:H7 Shiga toxin-producing E. coli, Salmonella, Shigella, and 
Yersinia) following standard culture assays, Clostridium difficile toxin by a 
cytotoxicity assay, parasites by microscopy and antigen testing [84]. 
Additionally, samples were tested by EIA for rotaviruses, adenoviruses, 
noroviruses 1 & 2, and astroviruses (Meridian Biosciences, DAKO). This study 
was approved by the institutional review boards of the CHRMC and of 
Washington University. 
 
Library construction and mass sequencing. 
Chips of frozen archived fecal specimens (~30-150mg) were resuspended 
in 6 volumes of PBS.  A subset of the archived specimens had been 
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previously diluted and were further diluted 1:1in PBS. The stool suspensions 
were centrifuged (9,700 x g, 10 minutes) and supernatants were harvested 
and then passed through 0.45µm filters. RNA was extracted from 100µL of 
the filtrates using RNA-Bee (Tel Test, Inc., Friendswood, Texas) according to 
manufacturers instructions. Approximately, 100-300 nanograms of RNA 
from each sample was randomly amplified following the Round AB 
protocol as previously described [41]. The amplified nucleic acid was 
cloned into pCR4 using the TOPO cloning kit (Invitrogen, Carlsbad, CA), 
and transformed into Top10 bacteria. Positive colonies were subcloned 
into 384 well plates, DNA was purified using magnetic bead isolation, and 
followed by sequencing using standard Big Dye terminator (v3.1) 
sequencing chemistry and the universal primer M13 reverse. Reactions 
were ethanol precipitated and resuspended in 25uL of water prior to 
loading onto the ABI 3730xl sequencer.  
 
Analysis of sequence reads.  
Sequence traces were subjected to quality assessment and base-calling 
using Phred [127,128]. Lucy [129] was used to trim vector and low quality 
sequences. Default parameters were used except that high quality 
sequences identified by Lucy were allowed to be as short as 75 
nucleotides. To define the set of reads with unique sequence content in 
each library, sequences that passed the quality filter were clustered using 
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BLASTClust from the 2.2.15 version of NCBI BLAST to eliminate redundancy. 
Sequences were clustered based on 98% identity over 98% sequence 
length, and the longest sequence from each cluster was aligned to the 
NCBI nr database using the tBLASTx algorithm [130].  An E-value cutoff of 
1e-5 was applied.  Sequences were phylotyped as human, bacterial, 
phage, viral, or other based on the identity of the best BLAST hit.  
Sequences without any hits having an E-value of 1e-5 or better were 
placed in the “Unassigned” category.  All eukaryotic viral sequences were 
further classified into viral families in similar fashion. 
Trimmed, high quality sequences that were not found by RepeatMasker to 
contain repetitive or low-complexity sequence have been deposited in 
Genbank (Accession numbers ET065304 through ET067293). 
 
Phylogenetic analysis. 
ClustalX (1.83) was used to perform multiple sequence alignments of the 
protein sequences associated with select sequence reads. Available 
nucleotide or protein sequences from known viruses were obtained from 
Genbank for inclusion in the phylogenetic trees.  Selected sequences 
from Genbank included those with the greatest similarity to the sequence 
read in question based on the BLAST alignments as well as representative 
sequences from all major taxa within the relevant virus family. The protein 
alignments created by ClustalX were input into PAUP [118], and maximum 
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parsimony analysis was performed using the default settings with 1,000 
replicates.  
 
Astrovirus trees: Human astrovirus 1 (NC_001943); Human astrovirus 2 
(L13745);  Human astrovirus 3 (AAD17224); Human astrovirus 4 (DQ070852); 
Human astrovirus 5 (DQ028633); Human astrovirus 6 (CAA86616); Human 
astrovirus 7 (AAK31913); Human astrovirus 8 (AF260508); Turkey astrovirus 1 
(Y15936); Turkey astrovirus 2 (NC_005790); Turkey astrovirus 3 (AY769616); 
Chicken astrovirus (NC_003790); Ovine astrovirus (NC_002469); and Mink 
astrovirus (NC_004579).   
 
Nodavirus tree: Striped Jack Nervous Necrosis virus (Q9QAZ8); 
Macrobrachium rosenbergii nodavirus (Q6XNL5); Black Beetle virus 
(YP_053043.1); Flockhouse virus (NP_689444.1); Epinephelus tauvina 
nervous necrosis virus (NC_004136.1); Nodamura virus (NC_002691.1); 
Boolarra virus (NC_004145.1); Pariacoto virus (NC_003692.1); and 
Redspotted grouper nervous necrosis virus  (NC_008041.1). 
 
Picornavirus trees: Human coxsackievirus A1 (AAQ02675.1), Human 
coxsackievirus A18 (AAQ04836.1), Human coxsackievirus A19 
(AAQ02681.1), Human coxsackievirus A21 (AAQ04838.1), Human 
coxsackievirus A24 (ABD97876.1), Human poliovirus 1 (CAD23059.1), 
Human coxsackievirus A2 (AAR38840.1), Human coxsackievirus A4 
(AAR38842.1), Human coxsackievirus A5 (AAR38843.1), Human 
coxsackievirus A16 (AAV70120.1), Human enterovirus 89 (AAW30683.1), 
Human enterovirus 91 (AAW30700.1), Human enterovirus 90 (BAD95475.1), 
Human enterovirus 71 (CAL36654.1), Echovirus 1 strain Farouk 
(AAC63944.2), Human coxsackievirus B2 (AAD19874.1), Human enterovirus 
86 (AAX47040.1), Human coxsackievirus B5 (AAF21971.1), Human 
echovirus 29 (AAQ73089.1), Human enterovirus 68 (AAR98503.1), Human 
enterovirus 70 (BAA18891.1), Bovine enterovirus (NP_045756.1), Porcine 
enterovirus A (NP_653145.1), Porcine enterovirus B (NP_758520.1), Simian 
enterovirus A (NP_653149.1), Human rhinovirus A (ABF51203.1), Human 
rhinovirus B (NP_041009.1). 
 
Picobirnavirus trees: Human picobirnavirus strain 1-CHN-97 (AF246939.1), 
Human picobirnavirus strain 4-GA-91 (AF246940.1), Human picobirnavirus 
strain Hy005102 (NC_007027.1), Human picobirnavirus strain 2-GA-91 
 - - 67 - - 
(AF245701.1), Human picobirnavirus strain 1-GA-91 (AF246612.1), Porcine 
picobirnavirus 2 (EU104360.1). 
 
 
Anellovirus trees:  TGP96 Torque teno virus (AB041962), Pt-TTV8-II Torque 
teno virus (AB041963),  CBD231 TTV-like mini virus  (AB026930), Mf-TTV9 
Torque teno virus (AB041959), Mf-TTV3 Torque teno virus (AB041958), 
KC009/G4 Torque teno virus (AB038621), TA278/G1 Torque teno virus 
(AB008394), Pt-TTV6 Torque teno virus (AB041957), TUS01/G3 Torque teno 
virus (AB017613), PMV/G2 Torque teno virus (AF261761), JT33F/G5 Torque 
teno virus (AB064606), MD1-073 Torque teno midi virus (AB290918), MD2-
013 Torque teno midi virus (AB290919), Tbc-TTV14 Torque teno virus 
(AB057358), Sd-TTV31 Torque teno virus (AB076001), Fc-TTV4 Torque teno 
virus (AB076003), Cf-TTV10 Torque teno virus (AB076002),  So-TTV2 Torque 
teno virus (AB041960), At-TTV3 Torque teno virus (AB041961). 
 
Calicivirus trees: Camberwell (AAD33960.1), MD-2004 (ABG49508.1), 
Carlow(ABD73935.1), Snow Mountain virus (AAN08111.1), Mc37 
(AAS47823.1), Hawaii(AAB97767.2), Norwalk(AAB50465.1), Southampton 
(AAA92983.1), Chiba(BAB18266.1), Hesse(AAC64602.1), BoJena-DEU-98 
(CAA09480.1), Murine (AAO63098.2), SU17(BAC11827.1), Dumfries 
(AAM95184.2), SU25-JPN(BAC11830.1), SU1-JPN(BAC11815.1), Desert Shield 
(AAA16284.1), Melksham (CAA57461.1), Toronto-24 (AAA18929.1), Sw918 
(BAB83515.1), OH-QW101 (AAX32876.1). 
 
Endonuclease-like sequences for D03 tree (mimvirus-like sequences): 
Bacteroides caccae (ZP_01959575.1), Acanthamoeba mimivirus 
(YP_142599.1), Eubacterium dolichum (ZP_02077753.1), Staphylococcus 
phage K (YP_024462.1), Lactobacillus phage LP65 (YP_164778.1), 
Lactococcus phage bIL170 (NP_047162.1), Lactococcus phage r1t 
(NP_695069.1), Burkholderia vietnamiensis G4 (YP_001119011.1), 
Streptococcus pyogenes (NP_607538.1), Tetrahymena thermophila 
(XP_001029162.1), Bacteroides vulgatus (YP_001300673.1) 
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Supplemental Figures: 
 
Supplemental Figure 2.S1: Phylogenetic analysis of picobirnavirus-like sequence reads. 
Phylogenetic trees were generated by comparing the translated amino acid sequence  
of individual sequence reads to members of the unclassified taxa picobirnavirus. The 
trees were created using the maximum parsimony method with 1,000 replicates. 
Bootstrap values over 700 are shown.  
 
 
 
Supplemental Figure 2.S2: Phylogenetic analysis of Picornaviridae-like sequence reads.  
Phylogenetic trees were generated by comparing the translated amino acid sequence 
of individual sequence reads to members of the Picornaviridae family. The trees were 
created using the maximum parsimony method with 1,000 replicates. Bootstrap values 
over 700 are shown. CVA=Coxsakievirus A, CVB=Coxsackievirus B, BEV=Bovine Enterovirus, 
EV=Enterovirus, HRVA=Human Rhinovirus A, HRVB=Human Rhinovirus B, PEV=Porcine 
Enterovirus, PV=Poliovirus, SEVA=Simian Enterovirus A. 
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Supplemental Figure 2.S3: Phylogenetic analysis of anellovirus-like sequence reads.  
Phylogenetic trees were generated by comparing the translated amino acid sequence 
of individual sequence reads to Anelloviruses. The trees were created using the maximum 
parsimony method with 1,000 replicates. Bootstrap values over 700 are shown.  
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Supplemental Figure 2.S4: Phylogenetic analysis of Caliciviridae-like sequence reads.  
Phylogenetic trees were generated by comparing the translated amino acid sequence  
of individual sequence reads to the A)  NS4 (3A-like) protein or B) NS7 (RNAP) protein of 
Caliciviruses. The trees were created using the maximum parsimony method with 1,000 
replicates. Bootstrap values over 700 are shown.  
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Supplemental Figure 2.S5: Phylogenetic analysis of endonuclease-like sequence reads.  
Phylogenetic trees were generated by comparing the translated amino acid sequence 
of two individual sequence reads to endonuclease sequences derived from mimivirus, 
phage, and bacterial species representing some of the top scoring BLAST hits.  The trees 
were created using the maximum parsimony method with 1,000 replicates. Bootstrap 
values over 700 are shown.  
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ABSTRACT 
Astroviruses infect a variety of mammals and birds and are causative 
agents of diarrhea in humans and other animal hosts.   We have 
previously described the identification of several sequence fragments with 
limited sequence identity to known astroviruses in a stool specimen 
obtained from a child with acute diarrhea, suggesting that a novel virus 
was present.  In this study, the complete genome of this novel virus isolate 
was sequenced and analyzed. The overall genome organization of this 
virus paralleled that of known astroviruses, with 3 open reading frames 
identified.  Phylogenetic analysis of the ORFs indicated that this virus is 
highly divergent from all previously described animal and human 
astroviruses.  Molecular features that are highly conserved in human 
serotypes 1-8, such as a 3’NTR stem-loop structure and conserved 
nucleotide motifs present in the 5’NTR and ORF1b/2 junction, were either 
absent or only partially conserved in this novel virus.  Based on the 
analyses described herein, we propose that this newly discovered virus 
represents a novel species in the family Astroviridae. It has tentatively 
been named Astrovirus MLB1.  
 
BACKGROUND 
Astroviruses are non-enveloped, single stranded, positive sense RNA 
viruses.  Their genomes range from approximately 6 to 8 kb in length, are 
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polyadenylated, and have both 5’ and 3’ non-translated regions (NTR) 
[131]. Their genomes have three open reading frames (ORFs) organized 
from 5’ to 3’ as follows: ORF 1a, which encodes a serine protease; ORF1b, 
which encodes the RNA dependent polymerase; and ORF 2, which 
encodes the structural proteins. A frameshift must occur during the 
translation of ORF1a in order for ORF1b to be translated.  ORF 2 is 
translated from a sub-genomic RNA and produces a polyprotein which is 
cleaved by cellular proteases [131].  
The family Astroviridae includes 8 closely related human serotypes 
as well as additional members that infect cattle, sheep, cats, dogs, deer, 
chickens, turkeys, and ducks [102]. Although some of the animal 
astroviruses are known to cause hepatitis or nephritis [104], astroviruses 
typically cause diarrhea in their hosts. Human astrovirus infections most 
frequently cause watery diarrhea lasting 2-4 days, and less commonly 
vomiting, headache, fever, abdominal pains, and anorexia in children 
under the age of 2, the elderly, and immunocompromised individuals 
[104]. The known human astroviruses account for up to ~10% of sporadic 
cases of non-bacterial diarrhea in children [84,85,105,132,133].  
Diarrhea is the third leading infectious cause of death worldwide 
and is responsible for approximately 2 million deaths each year as well as 
[80] an estimated 1.4 billion non-fatal episodes [81,82].  In children, 
rotaviruses, caliciviruses, adenoviruses and astroviruses are responsible for 
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the greatest proportion of cases [84-88]. Most epidemiological studies fail 
to identify an etiologic agent in  ~40% of diarrhea cases [89-93].  Recently, 
we conducted viral metagenomic analysis of diarrhea samples using a 
mass sequencing approach with the explicit goal of identifying novel 
viruses that may be candidate causes of diarrhea. One of the stool 
samples we analyzed was collected in 1999 at the Royal Children’s 
Hospital in Melbourne, Australia from a 3-yr old boy with acute diarrhea. 
Seven sequence reads were identified in this sample that shared ≤ 67% 
amino acid identity to known astrovirus proteins, suggesting that a novel 
astrovirus was present in the sample [134].  In this paper, we report the full 
sequencing and characterization of the genome of this astrovirus, referred 
to hereafter as astrovirus MLB1 (AstV-MLB1).  
 
RESULTS/DISCUSSION 
Genome sequencing and analysis.  In  the previous metagenomic 
study [134], we identified seven sequence reads with limited identity to 
known astroviruses that could be assembled into two small contigs in a 
clinical stool sample.  The contigs had 42-44%, and 59-61% amino acid 
identity to human astrovirus serine proteases and RNA-polymerases, 
respectively. In this study, the complete genome of the astrovirus present 
in the original stool specimen was sequenced to an average of >3X 
coverage [GenBank: FJ222451]. The virus has been tentatively named 
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Astrovirus MLB1 (AstV-MLB1). Analysis of the genome showed that AstV-
MLB1 has the same genomic organization as other astroviruses. Like other 
astroviruses, the AstV-MLB1 genome was predicted to encode three open 
reading frames (ORF1a, ORF1b, and ORF2) and contained both 5’ and 3’ 
non-translated regions (NTR), as well as a poly-A tail. The complete 
genome length of AstV-MLB1 was 6,171bp, excluding the poly-A tail, 
slightly shorter when compared to other astrovirus genomes which range 
in size between ~6,400 and 7,300bp [131]. A comparison of AstV-MLB1 
genomic elements with those of fully sequenced astroviruses is shown in 
Table 3.1.  
The ORF 1a of astroviruses encodes a non-structural polyprotein which 
contains a serine-like protease motif. Pfam analysis revealed a region of 
ORF1a that has homology to a peptidase domain. In addition, alignment 
of AstV-MLB1 with other astroviruses revealed that AstV-MLB1 contains the 
amino acids of the catalytic triad (His, Asp, Ser) which are conserved in 
the 3C-like protease motif found in other viruses (data not shown) [135]. 
The residues RTQ which have been suggested to be involved in substrate 
binding are conserved among the human astroviruses, but vary in other 
viruses which have the 3C-like motif [135]. In AstV-MLB1, the predicted 
substrate binding residues (ATR) are identical to those found in Ovine 
astrovirus and not those of the human astroviruses (data not shown).  
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Table 3.1: Genome Comparison of MLB1 to other astroviruses 
Virus 
Genome 
(bp) 
5' UTR 
(bp) ORF1a ORF1b ORF2 3' UTR 
Chicken AstV-1 6,927 15 3,017 1,533 2,052 305 
Turkey AstV-1 7,003 11 3,300 1,539 2,016 130 
Turkey AstV-2 7,325 21 3,378 1,584 2,175 196 
Mink AstV 6,610 26 2,648 1,620 2,328 108 
Ovine AstV 6,440 45 2,580 1,572 2,289 59 
Human AstV-1 6,813 85 2,763 1,560 2,361 80 
Human AstV-2 6,828 82 2,763 1,560 2,392 82 
Human AstV-4 6,723 84 2,763 1,548 2,316 81 
Human AstV-5 6,762 83 2,763 1,548 2,352 86 
Human AstV-8 6,759 80 2,766 1,557 2,349 85 
AstV-MLB1 6,171 14 2,364 1,536 2,271 58 
 
A second  feature of astrovirus ORF1a is the presence of a bipartite 
nuclear localization signal (NLS) found in human, chicken, and ovine 
astroviruses, but not turkey astroviruses [136]. A bipartite NLS is 
characterized as having two regions of basic amino acids separated by a 
10 aa spacer. The protein alignment of ORF1a revealed that AstV-MLB1 
has a sequence motif similar to the putative NLS of human astroviruses. 
This region of the genome has also been predicted to potentially encode 
for a viral genome-linked protein (VPg) [137]. The high sequence similarity 
observed between AstV-MLB1 and other astroviruses in the motifs 
identified as essential for a putative VPg suggests that AstV-MLB1 may also 
encode a VPg (data not shown). While no experimental data exists 
supporting the prediction of the presence of a Vpg being encoded in any 
of the astrovirus genomes, we should note that we did encounter difficulty 
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in obtaining the 5’ end of the MLB1 genome until treatment of the RNA 
with proteinase K prior to RNA extraction was added to the experimental 
protocol.  
Finally, the 2,364nt sequence of AstV-MLB1 ORF1a is shorter than 
ORF1a sequences of other astroviruses, which range between ~2,500-
3,300nt (Table 3.1). The shorter length of AstV-MLB1 ORF1a relative to the 
human astroviruses is largely attributable to two deletions totaling 57 
amino acids located within a highly conserved motif near the carboxyl 
terminus of human astroviruses 1-8. This deletion falls within a 144 aa region 
that has been mapped as being an immunoreactive epitope in human 
astroviruses [138] and is located in the non-structural protein p38 [135]. 
Recently, p38 has been reported to lead to apoptosis of the host cell 
which results in efficient virus replication [139] and particle release [140].  
However, it is unclear how the genome deletion identified in AstV-MLB1 
might influence these activities.  
Astrovirus ORF1b is classically generated by a -1 ribosomal frameshift 
induced by the presence of a heptameric ‘slippery sequence’ 
(AAAAAAAC). [102]. A conserved slippery sequence was identified near 
the end of ORF1a of Ast-MLB1 and FSFinder was used to determine if the 
downstream sequence was capable of forming a stem-loop structure, as 
found in other astoviruses [141]. The predicted start position of ORF1b was 
then determined by selecting the first amino acid in frame with the 
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slippery sequence. The 1b open reading frame of astroviruses encodes an 
RNA-dependent RNA polymerase (RNAP). Pfam analysis revealed that 
AstV-MLB1 ORF1b contains the RNA-dependent RNA polymerase domain 
found in other positive strand RNA viruses, suggesting this ORF does in fact 
encode for an RNAP.  
Astrovirus ORF2 encodes a large structural polyprotein that is 
cleaved by cellular proteases to generate the viral capsid proteins. 
Following the convention of human astroviruses [142,143] by choosing a 
start codon for ORF2 located two nucleotides upstream of the ORF 1b 
stop codon resulted in a predicted protein length of 756aa. Pfam analysis 
of the predicted protein encoded by ORF2 identifies an astrovirus capsid 
motif, thereby congruent with the paradigm of astrovirus genome 
organization in which ORF2 encodes the structural capsid proteins.  
The AstV-MLB1 ORF2 protein sequence was divided into four 
subregions for more detailed analysis as described [144]. Pair-wise 
comparisons of each region were conducted between the AstV-MLB1 
sequence and the sequences of all astroviruses for which sequences were 
available. Consistent with previous reports, region I appeared to be the 
most conserved of the four regions and in each of the regions, AstV-MLB1 
shared the most similarity to known human astroviruses.  However, even in 
region I, AstV-MLB1 only exhibited 33-35% identity to known human 
astroviruses. In the less conserved regions II-IV, AstV-MLB1 shared only 5-
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27% amino acid identity to the known human astroviruses.  By contrast, the 
range of identities between human astrovirus serotypes 1-8 were, 43-75%,  
16-66% and 28-77% for regions II,  III and IV, respectively. Overall, ASTV-
MLB1 maintained higher conservation in region I of ORF2 than in other 
regions, consistent with paradigms established by analysis of other 
astroviruses.  
 
Non-coding features. 
Multiple independent 5’ RACE experiments were performed to 
determine the precise 5’ end of the genome.  Based on these 
experiments, the AstV-MLB1 5’ NTR was determined to be 14nt long.  This is 
similar in length to the ~10-20nt 5’NTRs of avian astroviruses [131], but 
much shorter than the 80-85 nt long 5’NTRs of the 8 human astrovirus 
serotypes (Table 3.1). Notably, the human astroviruses share a 20nt 
consensus sequence at the terminal 5’ nucleotides of the genome which 
is not conserved in other astroviruses (data not shown). AstV-MLB1 
contained 13 out of the 20 consensus nucleotides, including the most 
5’CCAA motif within the this region [145] (Figure 3.1A). These data support 
the notion that the sequence we generated does contain the very 5’ 
terminus of the genome.  
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Figure 3.1: Multiple sequence alignments of putative astrovirus regulatory regions. 
A.) Alignment of the 20 nucleotides at the very 5’ end of the Astrovirus MLB1 genome 
with those of fully sequenced astroviruses. MLB1 only shares 13 of the 20 conserved 
nucleotides present in human strains 1-8. B.) Alignment of the 52nt highly conserved 
nucleotide motif (shown in box) present immediately upstream of the ORF1b/ORF2 
junction of Astrovirus MLB1 and other astroviruses. (Note: there is no overlap in the Turkey 
Astroviruses). MLB1 lacks the high degree of sequence identity seen between the human 
astroviruses. The start codon of ORF2 is shown underlined and the stop codon of ORF1b is 
shown italicized in bold for each virus.   
 
Human astroviruses contain a 120nt region at the junction between 
ORF1b and ORF2 that is ~95-97% conserved between serotypes [146]. The 
most highly conserved core 52nt region of this sequence is 99-100% 
identical among the human astrovirus serotypes. The exact role of this 
sequence is not known, but it is hypothesized to be a regulatory element 
of the sub-genomic RNA that encodes for ORF2. Alignment between AstV-
MLB1 and other human astroviruses of the highly conserved 52nt at the 
ORF1b/ORF2 junction revealed that AstV-MLB1 possessed only 61.5% 
identity in this region (Figure 3.1B).  By contrast, the known animal 
astroviruses share only 44-59.6% identity in this 52nt region with human 
 - - 83 - - 
astroviruses as determined by pair-wise comparisons.  Interestingly, AstV-
MLB1 shares 71.2% identity in this region to Ovine Astrovirus.  
All of the previously described astroviruses, with the exception of 
turkey astrovirus 2, have a conserved RNA secondary structure referred to 
as the stem-loop II-like motif (s2m) found at the 3’ end of the genome in 
the 3’ NTR [42]. This motif is also present in some coronaviruses and equine 
rhinovirus serotype 2. Mutations within this motif are generally 
accompanied by compensatory mutations that restore base pairing [42]. 
The conservation of such a sequence motif across multiple viral families 
suggests that it may play a broad role in the biology of positive stranded 
RNA viruses [42]. The exact function of this stem loop is not known, but it is 
hypothesized to interact with viral and cellular proteins needed for RNA 
replication. Nucleotide alignment of the 150 nucleotides at the 3’ terminus 
of the AstV-MLB1 genome and other viruses known to contain the stem-
loop motif suggested that AstV-MLB1 does not have this conserved 
nucleotide motif (data not shown). Furthermore, it also has the shortest 
3’NTR reported to date for an astrovirus. (Table 3.1) [131].  
Phylogenetic analysis.  Multiple sequence alignments of the three 
astrovirus open reading frames were performed and bootstrapped  
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maximum parsimony trees were 
generated (Figure 3.2). The trees 
confirmed initial assessments that 
AstV-MLB1 is a novel 
astrovirus[134]. The trees for ORFs 
1a and 1b (Figure 3.2A, B) both 
indicated that AstV-MLB1 is most 
closely related to the human 
astroviruses, although it is highly 
divergent from them. AstV-MLB1 
ORF1a only has 9-28% amino acid 
identity to other astrovirus ORF1a 
proteins and the pairwise 
sequence alignments of ORF1b 
revealed 35-54% amino acid 
identity between ORF1b proteins 
of AstV-MLB1 and other 
astroviruses (Table 3.2).  
Figure 3.2: Phylogenetic analysis of AstV-
MLB1 open reading frames.  
Phylogenetic trees are based on amino 
acid sequences and were generated 
using the maximum parsimony method 
with 1,000 bootstrap replicates. 
Significant bootstrap values are shown. 
(A) ORF1a; (B) ORF1b; (C) ORF2. HAstV = Human astrovirus; CAstV = Chicken astrovirus; 
MAstV = Mink astrovirus; TAstV = Turkey astrovirus; OAstV = Ovine astrovirus. 
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Table 3.2: Comparison of astrovirus proteins to predicted AstV-MLB1 proteins.  
Gene 
Est. 
Size 
(aa) % Amino Acid Identity to: 
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ORF 
1a 787 28 28 NA 29 29 NA NA 29 9 9 NA 10 22 24 
ORF 
1b 511 54 54 NA 54 54 NA NA 54 36 35 NA 36 47 44 
ORF 2 756 24 24 24 23 23 24 24 24 15 16 16 11 18 19 
 
The maximum parsimony tree for ORF2 (Figure 3.2C) shows that there is 
greater divergence among all of the sequences for ORF2, as is to be 
expected of the capsid region. However it is still evident that AstV-MLB1 is 
quite divergent from any of the known human astroviruses. Based on the 
predicted 756aa protein of ORF2, AstV-MLB1 has only 11-24% amino acid 
identity to other astrovirus capsid precursor proteins (Table 3.2). 
Origin of virus. At this point, the origin of AstV-MLB1 is unclear.   AstV-
MLB1 may be a bona fide human virus capable of infecting and 
replicating within the human gastrointestinal tract that had evaded 
detection until now.  Alternately, it may be a passenger virus present 
simply as a result of dietary ingestion, as has been described previously for 
plant viruses detected in human stool [78].  Of course, viruses derived from 
dietary intake that appear to cause human disease, such as Aichi virus, 
have been described previously [147,148].  Another possibility is that this 
virus may represent zoonotic transmission from some other animal species 
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that is the true host for Astrovirus MLB1.   Traditionally it has been thought 
that astroviruses have a strict species tropism. However, recent evidence 
has emerged that suggests that interspecies transmission does occur. For 
example, chicken astrovirus antibodies have been detected in turkeys 
[149] and an astrovirus was isolated from humans whose capsid sequence 
most closely resembled that of feline astrovirus[131]. Because of the 
uncertainty as to the identity of the true host species and the host range 
for this virus, we have tentatively named this novel virus Astrovirus MLB1 
(AstV-MLB1).  Efforts to define whether AstV-MLB1 is a novel human 
pathogen are underway. 
 
CONCLUSION 
Complete sequencing and genome analysis of Astrovirus MLB1 
revealed that the virus has three open reading frames sharing the same 
organization as other astroviruses. Phylogenetic analysis of the open 
reading frames clearly demonstrated that AstV-MLB1 is highly divergent 
from any of the known astroviruses. Furthermore, AstV-MLB1 lacks the 
conservation seen between human astroviruses 1-8 in the non-translated 
regions of the genome such as the 5’ and 3’ NTR and the ORF1b/2 
junction. The aggregate analysis of the non-coding features and ORFs as 
well as the phylogentic analysis clearly indicates that AstV-MLB1 is highly 
divergent from all previously described astroviruses.  
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  The divergence of AstV-MLB1 from known astroviruses in the non-
translated regions of the genome is particularly interesting because these 
regions are nucleotide motifs that are thought to play regulatory roles in 
viral replication. This suggests that AstV-MLB1 may behave very differently 
from the known astroviruses and that additional studies on the regulation 
of AstV-MLB1 transcription and replication may broaden our 
understanding of astrovirus paradigms.  
Astroviruses are associated with diarrhea predominantly in young 
children and immunocompromised individuals.  The discovery of AstV-
MLB1 in a liver transplant patient fits well with the known clinical 
parameters of astrovirus infection. We previously reported that the only 
other virus detected in this stool was a TT virus [134], which is thought to be 
non-pathogenic [150]. It is therefore tempting to speculate that AstV-MLB1 
is the pathogenic agent that caused this case of diarrhea. However, 
whether AstV-MLB1 is a bona fide human virus capable of causing 
diarrhea will have to be established by further experimentation and 
epidemiological surveys.  
 
Materials and Methods 
Specimen. A stool sample was collected from a 3 year old boy admitted 
to the Royal Children’s Hospital with acute diarrhea in 1999. The child had 
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previously undergone a liver transplant one year prior to this episode of 
diarrhea, however the immunological status was unknown. 
 
RNA extraction. RNA was isolated from the primary stool filtrate using RNA-
Bee (Tel-Test, Inc.) according to manufacturer’s instructions. In some cases, 
the stool filtrate was treated with 2.5 mg\ml proteinase K (Sigma) for 30 
min prior to RNA extraction.  
 
Genome amplification and sequencing. The astrovirus sequence reads 
previously detected in the primary stool filtrate  [134] [GenBank 
accessions: ET065575, ET065576, ET065577, ET065579, ET065580, ET065581, 
ET065582] were assembled into two contigs, and the nucleic acid 
between the contigs was obtained by RT-PCR.  For reverse transcription 
reactions, cDNA was generated with MonsterScript RT at 65ºC and 
amplified with Taq (Invitrogen).  Subsequent 5’ and 3’ RACE reactions 
were done to obtain the entire genome.  To generate high quality 
sequence coverage, 7 pairs of specific primers that spanned the 
complete genome in overlapping ~1kb fragments were used in RT-PCR 
reactions and then cloned and sequenced using standard Sanger 
sequencing chemistry.   All amplicons were cloned into pCR4.0 
(Invitrogen). These 7 primer pairs were used to confirm the sequence of 
the viral genome from both the primary stool sample and the passage 2 
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tissue culture sample. The complete genome sequence of AstV-MLB1 has 
been deposited in [GenBank: FJ222451].  
 
ORF prediction and annotation.  Open reading frames 1a and 2 were 
predicted for AstV-MLB1 using the NCBI ORF Finder program. ORF1b was 
predicted based on the frameshift paradigm that occurs in other 
astroviruses by identifying a heptameric slippery sequence [151].  
Conserved motifs were identified using Pfam [152]. 
 
Pair-wise alignments. Bioedit was used to determine the percent identity 
between sequences as determined by pair-wise alignments.  
 
Phylogenetic analysis. ClustalX (1.83) was used to carry out multiple 
sequence alignments of the protein sequences associated with all three 
of the open reading frames of representative astrovirus types. Maximum 
parsimony trees were generated using PAUP with 1,000 bootstrap 
replicates [118].  
Available nucleotide or protein sequences of the following astroviruses 
were obtained: Human Astrovirus 1 [GenBank: NC_001943]; Human 
Astrovirus 2 [GenBank: L13745];  Human Astrovirus 3 [GenBank: AAD17224]; 
Human Astrovirus 4 [GenBank: DQ070852]; Human Astrovirus 5 [GenBank: 
DQ028633]; Human Astrovirus 6 [EMBL: CAA86616]; Human Astrovirus 7 
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[Gen Bank: AAK31913]; Human Astrovirus 8 [GenBank: AF260508]; Turkey 
Astrovirus 1 [GenBank: Y15936]; Turkey Astrovirus 2 [GenBank: NC_005790]; 
Turkey Astrovirus 3 [GenBank: AY769616]; Chicken Astrovirus [GenBank: 
NC_003790]; Ovine Astrovirus [GenBank: NC_002469]; and Mink Astrovirus 
[GenBank: NC_004579].  
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ABSTRACT 
 The prevalence of the recently identified astrovirus MLB1 in a 
pediatric diarrhea cohort in St. Louis, USA was defined by RT-PCR. Of 254 
stool specimens collected in 2008, 4 were positive for astrovirus MLB1. 
These results demonstrate that astrovirus MLB1 is currently circulating in 
North America. 
 
BACKGROUND 
Astroviruses infect a variety of hosts including humans, turkeys, 
chicken, cattle, sheep, dogs, cats, deer, ducks and bats [102,103]. There 
are 8 known human serotypes which are genetically very closely related. 
Astroviruses typically cause diarrhea in their hosts and in humans 
symptoms normally last 2-4 days [104]. Children under the age of 2, elderly 
people, or otherwise immunocompromised individuals are most 
commonly affected [104]. Epidemiological studies suggest Human 
astroviruses 1-8 are responsible for up to ~10% of cases of acute, non-
bacterial diarrhea in children [84,85,105,132,133].  
  Recently, a highly divergent astrovirus, referred to as astrovirus 
MLB1 (AstV-MLB1), was identified in the stool of a three year old boy in 
Australia [134]. The entire genome of this novel virus was subsequently 
sequenced and characterized [153] . To date, there have been no 
published reports describing the presence of AstV-MLB1 outside of the 
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index case. In this study, the prevalence of this novel virus was determined 
by RT-PCR screening of pediatric stool samples collected at the St. Louis 
Children’s Hospital in St. Louis, MO, USA.  
 
RESULTS/DISCUSSION 
Pediatric stool specimens sent to the clinical microbiology lab for 
bacterial culture at the Saint Louis Children’s Hospital were analyzed for 
the presence of AstV-MLB1.  This study was approved by the Human 
Research Protection Office of Washington University in St. Louis.  Samples 
were collected January-May of 2008. Stools were diluted in PBS at a 1:6 
ratio (w/v) and total nucleic acid (TNA) was extracted from 200µL of each 
stool suspension using the MagNAPure LC Automated Nucleic Acid 
Extraction System (Roche).  
Previously described astrovirus primers Mon269 and Mon270 [154] 
have frequently been used for the detection of human astrovirus 
serotypes 1-8 in clinical stool specimens. However, the extensive 
divergence of AstV-MLB1 to the known human astroviruses rendered these 
primers unable to amplify AstV-MLB1 (data not shown). Since it is possible 
that AstV-MLB1 represents a new grouping of astroviruses that could 
include multiple subtypes, we designed primers to conserved regions of 
the AstV-MLB1 genome in order to maximize the likelihood of detection of 
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Figure 4.1: Astrovirus ORF1b alignments for design of pan-astrovirus primers 
Astrovirus RNA polymerase sequences (ORF1b) were aligned at the amino acid level in 
order to define the conserved regions used for the design of primers SF0073 (A) and 
SF0076 (B). The numbers to the right of the sequences indicate the position of the last 
amino acid within each ORF1b sequence. The amino acids outlined in the red boxes 
represent the specific regions that were reverse translated into the corresponding 
nucleic acid sequences used for the design of SF0073 (C) and SF0076 (D).  The red 
sequences shown in the nucleotide alignments are the actual primer sequences for 
SF0073 (C) and SF0076 (D). 
 
any AstV-MLB1 variant viruses, or even other novel astroviruses. Conserved 
regions were identified by performing multiple sequence alignments of 
AstV-MLB1 amino acid sequences to all fully sequenced astrovirus 
genomes (Figure 4.1A, 4.1B). The corresponding nucleotide sequences for 
these regions were then aligned in order to define the most highly 
conserved regions (Figure 4.1C, 4.1D). Two regions within ORF 1b were 
identified that yielded primers SF0073 (5’GATTGGACTCGATTTGATGG) and 
SF0076 (5’CTGGCTTAACCCACATTCC) that are predicted to generate a 
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~409 bp product.  Control experiments validated that this primer pair 
could detect AstV-MLB1 as well as Human astrovirus 1 (Figure 4.2). Given 
that some of the canonical human astroviruses are identical in the primer 
binding sites, this data suggests that at least some of the canonical 
human astroviruses can be detected by the primer pair SF0073/SF0076. In 
theory, under appropriate experimental conditions, these primers may 
also be able to detect all other known human and animal astroviruses, 
although that remains to be experimentally tested. These primers were 
used with the QIAGEN One-Step RT-PCR kit using the following cycling 
conditions: 30 min RT step, 94ºC hold for 10 min, followed by 40 cycles of 
94ºC for 30s, 52ºC for 30s, and 72ºC for 50s.  
 
 
Figure 4.2: Validation of screening 
primers SF0073 and SF0076 
Primers SF0073 and SF0076 were tested 
on stool filtrate made from the original 
AstV-MLB1 positive stool (Lane 2) as well 
as a Human astrovirus 1 positive stool 
specimen (Lane 3) using the QIAGEN 
One-Step RT-PCR kit as described in the 
text.  The products were visualized on a 
1.2% agarose gel. The expected size of 
the RT-PCR product generated with 
these primers is ~400bp. Lane 1 shows 
the Invitrogen 100bp DNA ladder for a 
size comparison. 
 
Samples that tested positive with primers SF0073 and SF0076 were 
then tested in a second round of screening with two different primer sets 
in parallel to determine if the samples contained canonical human 
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astrovirus serotypes 1-8 or AstV-MLB1. The previously reported Mon269 
(5’CAACTCAGGAAACAGGGTGT) and Mon270 
(5’TCAGATGCATTGTCATTGGT) primers, which generate a 449 bp 
amplicon, were used to detect canonical human astroviruses [154]. 
Another set of primers, SF0053 (5’CTGTAGCTCGTGTTAGTCTTAACA) and 
SF0061 (5’GTTCATTGGCACCATCAGAAC), was designed to exclusively 
detect AstV-MLB1 and produce a 402bp PCR product. These primers 
target a region of the capsid gene. The second round of screening with 
both sets of primer pairs was performed as described above with the 
exception that an annealing temperature of 56ºC was used.  
Of 254 stool specimens screened, 9 (3.5%) tested positive in the 
initial round of screening using the newly designed pan-astrovirus primers, 
SF0073 and SF0076. Secondary screening demonstrated that 5 (2% of all 
samples) were canonical human astroviruses. This is likely to be an 
underestimate of the astrovirus serotype 1-8 prevalence in the cohort 
since the initial screening primers were biased towards the detection of 
AstV-MLB1.  The remaining 4 (1.6% of all samples) were positive for AstV-
MLB1 using primers SF0053 and SF0061. For each of the 4 samples positive 
for AstV-MLB1, two additional fragments were generated by RT-PCR for  
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Figure 4.3: Phylogenetic Analysis of AstV-MLB1 isolates 
A region of the serine protease (A) and the capsid (B) of each virus detected by the 
AstV-MLB1 specific primers was amplified and sequenced. Multiple sequence alignments 
were then generated with these sequences and the corresponding regions of known 
astroviruses using ClustalX. PAUP was used to generate phylogenetic trees and bootstrap 
values (>700) from 1,000 replicates are shown. 
 
phylogenetic analysis. A 1228 bp fragment of ORF1a, which encodes the 
serine protease, and a 920 bp fragment of ORF2, which encodes the 
capsid proteins, were amplified using AstV-MLB1 specific primers from 
each of the 4 samples designated WD0016, WD0055, WD0104, WD0227. 
The primers used for the ORF1a fragment are SF0080 (5’-
AAGGATAGTGCTGGTAAAGTAGTTCAGA-3’) and SF0094 
 (5’-CAAGAGCCTTATCAACAACGTA-3’) and the primers used for the 
ORF2 fragment are SF0064 (5’-GTAAGCATGGTTCTTGTGGAC-3’) and 
SF0098 (5’-TGCATACATTTATGCTGGAAGA-3’). The ORF1a fragments 
(Genbank # ’s: FJ227120-FJ227123) from these samples all shared ~92%  
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Table 4.1: Similarity of fully sequenced WD0016 genome  to MLB1 
 
ORF1a          
(Serine 
Protease) 
ORF1b            
(RNA 
Polymerase) 
ORF2            
(Capsid) 
Nucleotide identity 
between WD0016 and 
MLB1 92.60% 93.90% 91.90% 
 
nucleotide identity to the reference astrovirus MLB1 sequence (Genbank 
# : FJ222451) and 99% amino acid identity, indicating that most mutations 
were synonymous. The ORF2 fragments (Genbank # ’s: FJ227124-FJ227127) 
shared ~91-92% nucleotide identity and 95-96% amino acid identity to the 
reference astrovirus MLB1 sequence. The 4 positive St. Louis samples 
shared ~99% nucleotide identity to each other. The ORF1a and ORF2 
sequences were aligned to other astroviruses for which full genome 
sequences were available using ClustalX (1.83), and then maximum 
parsimony trees were generated using PAUP with 1,000 bootstrap 
replicates [118] (Figure 4.3). The entire genome of one of the isolates, 
WD0016 (Genbank # : FJ402983 ), was sequenced and was determined to 
have 92.6% identity overall to that of AstV-MLB1 based on a pairwise 
nucleotide alignment. Table 4.1 shows the identity of WD0016 to the 
original MLB1 isolate for each open reading frame of the genome. 
Clinical and demographic information of patients with AstV-MLB1 
positive stools is shown in Table 4.2. The patients with AstV-MLB1 positive 
stools were between the ages of ~4mo-4yrs. All patients had symptoms of  
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Table 4.2: Clinical and demographic information of patients with AstV-
MLB1 positive stools 
 WD0016 WD0055 WD0104 WD0227 
Age (months) 15 17 4 43 
Gender Female Female Male Male 
Diarrhea No* Yes Yes Yes 
Other 
Symptoms 
abdominal 
pain 
vomiting, 
fever 
fever, seizures, 
respiratory 
distress 
fever 
Hospitalization Yes No Yes Yes 
Bacterial 
Cultures† 
Negative Negative Negative 
Positive for 
E. coli 
0157:H7 
* Patient had diarrhea two days prior to stool collection, but not at time of collection 
† Tests were conducted for E. coli, Campylobacter, Shigella, Salmonella, and Yersinia 
 
diarrhea at the time of stool collection, except for patient WD0016 who 
reported having diarrhea 2 days prior to the collection of the stool 
specimen. All specimens were tested for the presence of E. coli, 
Campylobacter, Yersinia, Shigella, and Salmonella by standard bacterial 
culture. WD0227 tested positive for E. coli 0157:H7, while the other samples 
were negative for all bacterial cultures. A pan-viral microarray, the  
ViroChip [20], was used to examine whether there were other 
viruses present in the stool of three (WD0055, WD0104, and WD0227) of the 
four AstV-MLB1 positive samples for which there was enough material left 
for analysis. WD0055 and WD0104 were negative by array, but WD0227 
was positive for rotavirus as determined by the ViroChip.  
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CONCLUSIONS 
The newly identified AstV-MLB1 virus was discovered in a stool 
specimen collected in Melbourne, Australia in 1999.  In this study, we 
describe the detection of AstV-MLB1 in a cohort from St. Louis, USA 
collected in 2008.  This observation provides the first evidence that AstV-
MLB1 is present outside of Australia, and suggests that AstV-MLB1 is likely to 
be globally widespread.  In addition, these data demonstrate that AstV-
MLB1 is currently circulating in the human population.  The observed 
sequence divergence of ~8% at the nucleotide level between the 
reference AstV-MLB1 genome and the viruses detected in this study 
suggests that there may be significant sequence heterogeneity within the 
AstV-MLB1 group of viruses.  It is possible that multiple serotypes or 
subtypes of AstV-MLB1 exist, as is the case with the canonical human 
astroviruses.  More extensive screening of stool samples with PCR primers 
targeted toward detection of AstV-MLB1 such as those described in this 
paper may provide insight into the true diversity and prevalence of AstV-
MLB1-like viruses.  Finally, a critical direction for future investigation is 
determining whether AstV-MLB1, like the canonical astrovirus serotypes 1-8, 
is a causal agent of human diarrhea, and if so, what is the disease burden 
associated with this virus.  To begin addressing this question, further 
epidemiologic studies, including both case-control prevalence studies 
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and seroprevalence assays, and efforts to fulfill Koch’s postulates should 
be pursued. 
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ABSTRACT 
 
Viral gastroenteritis is one of the most common human illnesses worldwide 
and is a major cause of morbidity and mortality in infants and young 
children. Despite the availability of improved molecular diagnostics to 
detect known viral agents, the etiology of a large proportion of diarrheal 
cases is unknown.  The advent of metagenomic sequencing approaches 
has revolutionized the process of pathogen discovery.  In this study, 
parallel efforts applying both random Sanger sequencing and high 
throughput pyrosequencing were used to analyze fecal specimens 
obtained from an outbreak of acute gastroenteritis in a child care center. 
The specimens tested negative for known bacterial, parasitic and viral 
enteric pathogens by conventional assays.  Sequences consistent with 
astroviruses were identified by both techniques, 72 sequence reads by the 
low through-put Sanger sequencing and 1339 sequencing reads by high 
through-put pyrosequencing.  Assembly of these reads into contigs and 
subsequent RT-PCR and RACE experiments yielded a complete genome 
of 6,586 nucleotides.  Phylogenetic analysis of the three predicted open 
reading frames from this newly identified astrovirus, tentatively named 
Astrovirus VA1 (AstV-VA1), demonstrated that AstV-VA1 was highly 
divergent from all previously described human and animal astroviruses 
and most closely related to mink and ovine astroviruses.   Using AstV-VA1 
specific RT-PCR assays, 3 of 5 fecal specimens from symptomatic 
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individuals in this outbreak tested positive, raising the possibility that AstV-
VA1 may be a causal agent of acute gastroenteritis. 
 
 
INTRODUCTION 
 
Astroviruses are known to infect a variety of avian and mammalian 
species [102,103] and typically cause diarrhea [104].  They are thought to 
be host specific with little evidence for cross-species transmission [131].  In 
humans, 8 serotypes of astroviruses have been described [131].  Clinical 
symptoms usually last 2-4 days and consist of watery diarrhea and, less 
commonly, vomiting, headache, fever, abdominal pains, and anorexia 
[104].  
Astroviruses consist of a family of small, single-stranded, positive-
sense RNA viruses. Their genomes are organized into three open reading 
frames denoted ORFs 1a, 1b, and 2, which encode a serine protease, 
RNA-dependent RNA polymerase (RdRP), and a capsid precursor protein, 
respectively [131]. At both the 5’ and 3’ ends, non-translated regions (NTR) 
flank the 6.1-7.3kb sized genomes [131,153].  Two characteristic features of 
astroviruses are the dependency on a ribosomal frameshift for the 
translation of ORF1b and the generation of a sub-genomic RNA from 
which ORF2 is translated [131].  
Human astroviruses have been associated with up to ~10% of 
sporadic cases of viral diarrhea in children [84,85,105,132,133] and with 
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0.5-15% of outbreaks [94,95,155]. Significantly, in some reports the 
etiologies of 12-41% of the outbreaks remain undetermined even after 
extensive testing, suggesting that there is a diagnostic gap [94,95]. 
Similarly, on average, approximately 40% of the cases of sporadic 
diarrhea are unexplained [89-93].  In previous efforts to identify novel 
candidate pathogens present in sporadic cases of diarrhea in humans, 
we used high throughput sequencing to identify a novel astrovirus 
(Astrovirus MLB1) [134,153] and a novel picornavirus (Cosavirus E1) [156]. 
The role of these viruses in causing diarrhea remains unclear. In this paper, 
we applied mass sequencing to analyze specimens obtained from an 
unexplained outbreak of gastroenteritis. We report the identification and 
complete genome sequencing of yet another novel astrovirus, referred to 
as Astrovirus VA1 (AstV-VA1), associated with a gastroenteritis outbreak at 
a child care center.  
 
RESULTS 
  
Genome sequencing and analysis 
 Five fecal specimens (labeled A, B, C, D and E) were collected from 
a gastroenteritis outbreak at a child care center in Virginia (Table 5.1). 
Following high throughput pyrosequencing of RNA and DNA extracted 
from samples A, B, C and D (average of 12,730 reads per sample), we 
found 313 unique high quality sequence reads in sample B and 1,017 
unique high quality reads in sample C most closely related to astroviruses.    
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Table 5.1:  Epidemiologic data of the 5 specimens from a child care 
center outbreak of acute gastroenteritis. 
Sample 
ID 
Sex Age Onset 
Date 
Sample 
Date 
Symptoms 
A M 2 years 8/19/08 
 
8/19/08 
 
Diarrhea, 
vomiting 
B F 36 years 8/26/08 
 
8/28/08 
 
Diarrhea, 
vomiting 
C M 6 months 8/25/08 
 
8/25/08 
 
Diarrhea 
D M 19 
months 
8/5/08 
 
8/26/08 
 
Diarrhea 
E Unknown 20 
months 
8/5/08 
 
8/27/08 
 
Diarrhea 
 
A 6,376 nucleotide (nt) contig was assembled from the astrovirus-like 
sequences detected in sample B and 4 contigs totaling 6,026 nucleotides 
were assembled from sample C. The translated contigs had only limited 
sequence similarity (37-71% aa identity) to proteins from mink and ovine 
astroviruses, suggesting the presence of a potentially novel astrovirus in 
these samples.  Because the nucleotide sequences obtained in samples B 
and C were nearly identical, the five original contigs were assembled to 
generate a larger contig of 6,581 nucleotides in length. 
Independently, four of the five fecal samples (stool samples A, B, C 
and E) were analyzed by Sanger sequencing.  3 out of 96 clones from 
sample B and 69 out of 152 clones from sample C contained sequence 
signatures that were most closely related to previously known astroviruses 
by Blastn similarity searches.  Sequencing of 100 clones each from samples 
A and E yielded no clones with detectable similarity to astroviruses. The 
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sequences of the 69 clones from sample C were assembled into 4 contigs.  
Primers were then designed to generate a series of eight overlapping RT-
PCR amplicons with an average size of ~900 bp that yielded a genomic 
sequence of 6,537 nt.  In order to define the 5’ end of the genome, three 
independent 5’RACE reactions were performed and a total of 23 clones 
from these reactions were sequenced.  All clones extended the genome 
by 49 nt and yielded the identical 5’end sequence, suggesting that the 
genome was complete with a total length of 6,586 nt, excluding the poly-
A tail.  Comparison of the genome sequences generated by the two 
sequencing methods yielded nearly identical sequences, with the 
exception of 5 missing nucleotides at the 5’ end of the contig generated 
by pyrosequencing and 3 nucleotide substitution differences. These were 
resolved by direct PCR sequencing to generate the final, corrected 
sequence.  This virus has been provisionally named Astrovirus VA1 (AstV-
VA1). 
The genome of AstV-VA1 had three predicted open reading frames 
as well as non-translated regions (NTRs) at both the 5’ and 3’ ends of the 
genome.  Several conserved protein motifs were identified including a 
serine protease in ORF1a, an RNA dependent RNA polymerase in ORF1b, 
and capsid protein in ORF 2. ORFs 1a and 2 were predicted by the NCBI 
ORF Finder program; however the full coding region for ORF1b was not 
predicted by the program because translation of ORF1b is dependent on  
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Table 5.2: Genome Comparison of MLB1 to other astroviruses 
Virus 
Genome 
(bp) 
5' UTR 
(bp) ORF1a ORF1b ORF2 3' UTR 
Chicken AstV-1 6,927 15 3,017 1,533 2,052 305 
Turkey AstV-1 7,003 11 3,300 1,539 2,016 130 
Turkey AstV-2 7,325 21 3,378 1,584 2,175 196 
Mink AstV 6,610 26 2,648 1,620 2,328 108 
Ovine AstV 6,440 45 2,580 1,572 2,289 59 
Human AstV-1 6,813 85 2,763 1,560 2,361 80 
Human AstV-2 6,828 82 2,763 1,560 2,392 82 
Human AstV-4 6,723 84 2,763 1,548 2,316 81 
Human AstV-5 6,762 83 2,763 1,548 2,352 86 
Human AstV-8 6,759 80 2,766 1,557 2,349 85 
AstV-MLB1 6,171 14 2,364 1,536 2,271 58 
AstV-VA1 6,586 38 2,661 1,575 2,277 98 
 
a -1 ribosomal frameshift that occurs during translation [151]. This 
frameshift is thought to be mediated by the presence of a heptameric 
‘slippery sequence’ (AAAAAAAC) near the end of ORF1a [151], which 
was also conserved in the AstV-VA1 sequence, suggesting that this new 
virus follows the same paradigm.  The sequence 
AUUUGGAGNGGNGGACCNAAN5-8AUGNC located upstream of ORF2, 
which has been proposed as the promoter for subgenomic RNA synthesis 
in all previously known astroviruses [131], is also present in AstV-VA1 with 
only 2 nt differences.  The predicted size for each of the open reading 
frames is 2,661 nt, 1,575 nt, and 2,277 nt for ORFs 1a, 1b, and 2, 
respectively. These sizes are similar to the ORF sizes of mink and ovine 
astroviruses (Table 5.2). 
 - - 109 - - 
The 5’ non-translated region (NTR) of AstV-VA1 is 38 nt in length, 
which is between the lengths of the 5’ NTRs of mink astrovirus (26 nt) and 
ovine astrovirus (45 nt). The 3’ NTR is 98 nt in length, which again is 
intermediate between the length of the NTRs of ovine astrovirus (59 nt) 
and mink astrovirus (108 nt). The 3’ NTR of nearly all astroviruses contains a 
highly conserved RNA secondary structure called the stem-loop II-like 
motif (s2m), which has also been identified in several coronaviruses and in 
equine rhinovirus 2 [42,157]. An alignment of the 150 nt just upstream of 
the poly-A tail of AstV-VA1 along with the 3’ terminal sequences of other 
astroviruses known to contain the s2m motif indicated that AstV-VA1 
contains the highly conserved ~33 nucleotide core of the s2m motif, with 
100% identity to other astroviruses in this region. The exact role of this motif 
is not understood; however its presence in multiple viral families suggests it 
may play an important role in the replication of these viruses. 
 
Phylogenetic analysis 
Multiple sequence alignments were independently carried out for 
each of the three predicted ORFs. Maximum parsimony trees confirmed 
that AstV-VA1 was highly divergent from but most closely related to mink 
and ovine astrovirus in all three ORFs (Figure 5.1). Furthermore, the greatest 
sequence identity between AstV-VA1 and mink and ovine astroviruses is in 
ORF1b with 61% amino acid identity to mink astrovirus and 62% to ovine  
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Figure 5.1: Phylogenetic analysis of 
AstV-VA1 open reading frames.  
Phylogenetic  trees were generated in 
PAUP using the maximum parsimony 
method with 1,000 bootstrap replicates. 
Significant bootstrap values are shown. 
(A) ORF1a-serine protease; (B) ORF1b-
polymerase; (C) ORF2-capsid. HAstV 
=Human astrovirus 
 
 
 
astrovirus. The ORF1a (serine 
protease) coding region was 
more divergent with 39% and 
40% amino acid identity with 
ovine astrovirus and mink 
astrovirus, respectively. In ORF2, 
AstV-VA1 shared 41% amino 
acid identity to mink astrovirus 
and 42% to ovine astrovirus.  
 
 
RT-PCR screening for AstV-VA1 
High throughput 
pyrosequencing yielded many 
AstV-VA1 sequences in samples B and C, but none were detected in 
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samples A or D.  Sample E was not analyzed by pyrosequencing due to 
technical problems with the sample preparation. Similarly, Sanger 
sequencing detected AstV-VA1 positive reads in samples B and C, but not  
in samples A and E (sample D was not initially tested). To determine 
whether low levels of AstV-VA1 might be present in samples A, D and E, 
real time RT-PCR and semi-nested RT-PCR assays were developed 
targeting regions in ORF1b and ORF2, respectively.  Using these assays, 
sample D tested positive and sequencing of the 250 bp amplicon 
confirmed the presence of AstV-VA1.  
 
 
DISCUSSION  
 
Despite the availability of improved molecular diagnostic methods 
for the detection of gastroenteritis viruses in humans such as norovirus, 
rotavirus, astrovirus, adenovirus, and sapovirus, the etiology of 12-41% of 
the outbreaks of gastroenteritis remain unexplained [94,95], In this study, 
we identified a novel astrovirus (AstV-VA1) in fecal samples from an 
outbreak of acute gastroenteritis in a child care center by two sequence 
independent genome amplification and sequencing methods, high 
throughput pyrosequencing and low throughput Sanger sequencing.  
Both methods identified and thus confirmed the presence of a novel 
astrovirus.  
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Complete genome sequencing and phylogenetic analysis 
demonstrated that AstV-VA1 was highly divergent from all previously 
described astroviruses including the 8 human astrovirus serotypes and 
recently described astrovirus MLB1 (AstV-MLB1). AstV-VA1 appears to 
have diverged from a common ancestor of the mink and ovine 
astroviruses following their separation from the branch containing human 
astroviruses 1-8 and astrovirus MLB1.  The discovery of AstV-VA1 following 
the recent identification of AstV-MLB1 clearly demonstrates that a much 
greater diversity of astroviruses exists in humans than is commonly 
recognized. 
The detection of AstV-VA1 in three out of five samples of this 
gastroenteritis outbreak suggests a potential association between AstV-
VA1 and symptomatic infection. The fact that AstV-VA1 was only 
detected in sample D by targeted PCR assays and not by either of the 
mass sequencing methods may be due to the late timing of sample 
acquisition relative to the onset of symptoms (Table 1).  Further studies 
defining the frequency of detection of AstV-VA1 in additional samples 
from individuals with and without acute gastroenteritis are needed to 
define the role of AstV-VA1 in human diarrhea. It is likely that the 
application of sequence independent amplification and sequencing 
methods to other outbreaks of gastroenteritis of unknown etiology will 
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identify other novel viruses and expand our ability to determine the cause 
of diarrheal disease. 
 
 
MATERIALS AND METHODS 
 
Outbreak  
 
On Monday, 8/18/2008, the Eastern Shore Health District in Virginia was 
notified of cases of gastrointestinal illness among 26 teachers and children 
in a child care center over a period of 2 to 3 weeks. Symptoms included 
vomiting, and/or diarrhea.  Control measures were put in place 
immediately at the center including exclusion of symptomatic children, 
mandated testing of all symptomatic staff, testing of symptomatic 
children, environmental disinfection of surfaces and ultimately, temporary 
closing of the facility. Five fecal specimens (A- E) (Table 5.1)  that tested 
negative for enteric parasites, enteric bacteria by standard microscopy 
and culture, and negative for enteric viruses including rotavirus 
(RotaClone EIA), norovirus, sapovirus, human astrovirus, and adenovirus 
gp F by (RT)-PCR [92,158,159], were available for further testing.  
 
Genome amplification and Sequencing. 
 
The fecal specimens were further analyzed independently in two 
laboratories. At Washington University, the specimens were diluted in PBS 
at a 1:6 ratio (w/v) and total nucleic acid was extracted from 200µL of 
each fecal suspension using the MagNAPure LC Automated Nucleic Acid 
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Extraction System (Roche). Total nucleic acid was randomly amplified 
using the Round AB protocol as previously described with the exception 
that each sample was independently amplified with a different modified 
primer B containing a unique 6-nucleotide barcode at the 5’ end of the 
primer [41]. Amplification products from multiple samples were pooled, 
adaptor-ligated, and sequenced using the Roche GS-FLX Titanium 
platform (Roche) at the Washington University Genome Sequencing 
Center.  
Sequences from each sample were identified by the unique 
barcodes introduced during the Rd B amplification. Primer and barcode 
sequences were then trimmed off prior to analysis of the sequences. 
Sequences were clustered using CD-HIT [160] to reduce redundancy with 
the requirement that they had to be 98% identical over 98% of their 
lengths. The longest sequence from each cluster was selected for 
inclusion in the pool of unique sequences to be analyzed.  Unique 
sequences were filtered for repetitive sequences and compared with the 
human genome using BLASTn with an e-value cutoff of 1e-10. Sequences 
without significant similarity to the human genome were then compared 
to the GenBank nucleic acid nt database using BLASTn (cutoff: 1e-10) and 
tBLASTx (cutoff: 1e-5), and remaining sequences without significant hits to 
sequences in the database were then compared to the NCBI All Viral 
Genome database (ftp://ftp.ncbi.nih.gov/refseq/release/viral/) using 
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tBLASTx (cutoff: 1e-5)  [130].  Overlapping sequences with significant 
sequence identity were assembled into contigs using Newbler (454 Life 
Sciences) or CAP3 [161].  
At CDC, 10% fecal suspensions were first clarified by centrifugation 
at 
6,000×g for 10 minutes and the supernatant was then filtered through a 
0.22-um filter (Ultrafree MC; Millipore, Bedford, MA). Total nucleic acid 
(TNA) was extracted from 200 µl of the cleared supernatant fluid with the 
QIAamp MinElute Virus Spin kit (QIAGEN, Valencia, CA) according to the 
manufacturer’s instructions. After elution from the column in 50 µl of 
RNase-free water, TNA was randomly amplified using the Round AB 
protocol as previously described [41]. The 300-800bp amplicons were then 
cloned using the TOPO TA cloning kit (Invitrogen, Carlsbad, CA) and 
plasmids were sequenced with a BigDye Terminators v3.1 ready reaction 
cycle sequencing kit on an ABI Prism 3130 automated sequencer (Applied 
Biosystems, Foster City, CA).  Sequence analysis and generation of contigs 
were performed using Sequencher software (Ann Arbor, MI, USA). 
Sequence identification was performed through NCBI nucleotide–
nucleotide BLASTn similarity searches 
(http://www.ncbi.nlm.nih.gov/blast/Blast.cgi).  In addition, a set of eight 
overlapping RT-PCR products with an average size of 900 bp which cover 
the entire genome including the 3’ end poly A tail were generated by 
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primer pairs designed from clone sequences as described above, using 
the SuperScript III First-Strand Synthesis System for RT-PCR and AccuPrime 
High Fidelity Taq DNA polymerase (Invitrogen, Carlsbad, CA, USA).  Both 
strands of each amplicon were sequenced with a BigDye Terminators v3.1 
ready reaction cycle sequencing kit as described above.   The 5’ end 
genome sequence was amplified and determined using the 5’ / 3’ RACE 
Kit (Roche, Mannheim, Germany) following the manufacturer’s instructions.  
The complete genome sequence of AstV-VA1 has been deposited in 
Genbank (number will be added once acquired).  
 
ORF Prediction and annotation. 
Open reading frames (ORFs) 1a and 2 were predicted by the NCBI 
ORF finder (http://www.ncbi.nlm.nih.gov/projects/gorf/). The end of 
ORF1b was predicted by the program, however the start of ORF1b was 
predicted based on the location of the heptameric slippery sequence 
found in other astroviruses [151]. Protein motifs were identified by 
conserved domain searches using BlastX and Pfam [152,162-164]. 
 
Pair-wise alignments.  
Bioedit was used to determine the percent identity between sequences 
as determined by pair-wise alignments.    
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Phylogenetic analysis.  
ClustalX (1.83) was used to carry out multiple sequence alignments of the 
protein sequences associated with all three of the open reading frames of 
astroviruses for which sequences were available. Maximum parsimony 
trees were generated using PAUP with 1,000 bootstrap replicates [118]. 
Available nucleotide or protein sequences of the following astroviruses 
were obtained: Human Astrovirus 1 [GenBank: NC_001943]; Human 
Astrovirus 2 [GenBank: L13745];  Human Astrovirus 3 [GenBank: AAD17224]; 
Human Astrovirus 4 [GenBank: DQ070852]; Human Astrovirus 5 [GenBank: 
DQ028633]; Human Astrovirus 6 [EMBL: CAA86616]; Human Astrovirus 7 
[Gen Bank: AAK31913]; Human Astrovirus 8 [GenBank: AF260508]; Turkey 
Astrovirus 1 [GenBank: Y15936]; Turkey Astrovirus 2 [GenBank: NC_005790]; 
Turkey Astrovirus 3 [GenBank: AY769616]; Chicken Astrovirus [GenBank: 
NC_003790]; Ovine Astrovirus [GenBank: NC_002469]; Mink Astrovirus 
[GenBank: NC_004579], Astrovirus MLB1 [GenBank:   NC_011400], and Bat 
Astrovirus [GenBank: EU847155]. 
 
Real Time assay: 
The real-time RT-PCR assay was performed using the SuperScriptTM III One-
Step RT-PCR kit (Invitrogen Corp., Carlsbad, CA) and the Mx4000® system 
(Stratagene, La Jolla, CA). Each 50ul reaction mixture contained 900 pmol 
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of forward primer (5' TAT CCA TAG TTG TGG ATA TTT GTC CA 3' ), 1000 
pmol of reverse primer (5' TGT CTT AGG GGA GAC TTG CAA A 3' ) and 100 
pmol of probe (5' TT CC CCCT GTC CTG GAT TGT CAC TTC 3'), 1x buffer, 
6.0 mM MgSO4 (final concentration), 20 units of RNase inhibitor, a 5 µl 
aliquot of RNA extracts, and 1 unit of SuperScript III RT/Platinum Taq Mix.  
Water was added to achieve a final volume of 50 µl.  The RT-PCR reaction 
mixture was incubated at 60ºC for 1 minute for denaturing, 50ºC for 30 
minutes (for RT), 94ºC for 2 minutes (for hot start), then 40 cycles at 94ºC for 
15 seconds; 55ºC for 30 seconds; 72ºC for 30 seconds and a final extension 
at 72ºC for 7 minutes. Fluorescence measurements were taken and the 
threshold cycle (CT) value for each sample was calculated by 
determining the point at which fluorescence exceeded a threshold limit 
set at the mean plus 10 standard deviations above the baseline.   
 
Semi-nested RT-PCR assay: 
The first round RT-PCR in the semi-nested assay was performed according 
to the protocol described previously [165] using forward primer (5' AGG 
GGT CGC TGG GAG TTT G 3') and reverse primer (5' GTC TAT TGT TTT GGG 
CGT CTG C 3'). The 2nd round PCR in the semi-nested assay PCR assay in 
50ul reaction mixture contained  1x buffer (Platinum Taq kit; Invitrogen), 2 
mM MgCI2, 200uM (each) of deoxynucleoside triphosphates, 50 pmol 
(each) of forward primer (5' AGG GGT CGC TGG GAG TTT G 3' ) and 
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reverse primer (5' CGG GGG TGG TGC GAC AT 3')  1 U Platinum Taq, one 
2-ul aliquot from the first reaction, and water to achieve a final volume of 
50 ul. The mixture was first heated to 94°C for 2 min. The cycling conditions 
were 40 cycles with the same conditions as for the first amplification: 94°C 
for 15 s, primer annealing at 55°C for 30 s, and 72°C for 30 s. A final 
extension was carried out at 72°C for 7 min. The final seminested PCR 
products were visualized by UV light after electrophoresis on a 2% agarose 
gel containing 0.5 ug/ml ethidium bromide in 0.5 x Tris-borate buffer. 
Amplicons from the final round of PCR were purified using the QIAquick 
PCR purification kit (Qiagen, Inc., Valencia, CA). Both strands of the 
amplicons were sequenced with a BigDye Terminators v3.1 ready reaction 
cycle sequencing kit as described above. 
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In the developed world, diarrhea is not commonly thought of as a 
major health concern. However, diarrhea is a yet unsolved problem given 
that it is still the third leading cause of death due to an infectious disease. 
Since ~40% of all cases are of unknown etiology, there is a major gap in 
our understanding of the causes of diarrhea. Not fully understanding the 
problem hinders the development of comprehensive tactics for 
prevention and treatment of diarrhea. My doctoral thesis work was aimed 
at addressing the existing gap in knowledge and has served to make 
important strides towards potentially closing this gap.  
Currently, there is building excitement about the Human 
Microbiome Project which is a National Institutes of Health multi-institute 
iniative to use mass sequencing to determine the microbial populations 
associated with humans at various sites of the body. However, this is a 
new found excitement. Few people were talking about metagenomic 
analysis of human-associated microbial communities at the time in which 
this thesis work began. While some groups had examined the spectrum of 
viruses present in stools from healthy adults, and that is in part what the 
Human Microbiome Project proposes to do further, no one had previously 
examined what spectrum of viruses can be found in diarrhea samples. My 
initial analysis of 12 diarrheal stools was therefore the first snapshot of the 
diarrhea virome. This analysis revealed that the spectrum of viruses 
associated with diarrhea is highly varied in terms of the families of viruses 
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found in a given sample, the numbers of different viruses in a given 
sample, and the relative abundance of viruses in the samples. This 
suggests that the complexity of the human diarrhea virome is quite 
complex and highlights the difficulty of assessing the role of an individual 
virus in causing diarrhea when there is a complex mixture of viruses 
present in a sample.  
Perhaps the most exciting finding that came out of the 
metagenomic analysis of the first 12 diarrhea samples was that there were 
many novel viruses present in the samples. The identification of multiple 
novel viruses in just a small random sampling of diarrhea specimens 
provides confidence that there are still many unknown viruses to be 
discovered and provides further encouragement to continue searching 
for them.  
One of the novel viruses that was identified belongs to the family 
Nodaviridae. The identification of this virus perfectly exemplifies the 
possibility for paradigm shifting discoveries. Nodaviruses are known to 
infect fish and insects, but do not naturally infect humans. The 
identification of a novel nodavirus in a human diarrhea specimen presents 
the possibility that the virus infects humans. There are other explanations 
though. For example, it is possible that the virus was derived from some 
dietary source, perhaps an infected fish, and was simply passed through 
the gastrointestinal tract. However, if it can be demonstrated that this 
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novel nodavirus does infect humans, it would be an exciting finding since 
this virus would be the first nodavirus known to infect humans. Discoveries 
of viruses like this one points out the need to have an unbiased approach 
to search for novel viruses and furthermore for thinking about what the 
potential causes of diarrhea might be. Of course, much more work needs 
to be done in order to discern between the possible explanations for the 
nodavirus’ presence in the diarrhea sample. 
The most promising discovery of the initial metagenomic analysis 
was that of a novel astrovirus, AstV-MLB1, in an Australian diarrhea 
specimen. Phylogenetic analysis revealed that AstV-MLB1 is highly distinct 
from any of the known astroviruses, including the known human 
astroviruses, confirming that AstV-MLB1 is in fact a highly divergent, novel 
astrovirus. Given that astroviruses are known to infect humans and that 
they typically cause diarrhea in their hosts it is easy to believe that this 
astrovirus could also cause diarrhea in humans, however that has yet to 
be proven. The detection of AstV-MLB1 in additional diarrhea specimens 
from Saint Louis is the first report examining the prevalence of AstV-MLB1 
and the first detection of AstV-MLB1 outside of Australia. Detection of 
AstV-MLB1 on two continents suggests that the virus may be globally 
widespread, suggesting that if it is shown to be a human pathogen it may 
affect a wide distribution of people around the world.  
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The identification of MLB1 was followed by the identification of yet 
another highly divergent, novel astrovirus. This astrovirus, AstV-VA1, was 
found in 3/5 samples from a gastroenteritis outbreak. The identification of 
AstV-VA1 in association with a diarrhea outbreak presents a very strong 
possibility that this astrovirus is in fact associated with diarrhea.  
While astroviruses are known to cause diarrhea, they have generally 
been associated with at most 10% of both sporadic and outbreak cases 
of acute diarrhea. The identification of two novel astroviruses in human 
diarrhea samples hints that astroviruses may have a larger role in causing 
human diarrhea than previously believed. There are 8 known human 
astroviruses which are all very closely genetically related. Following that 
example, it is possible that each of these viruses represents a whole new 
cluster of astroviruses. One could furthermore hypothesize that these novel 
astroviruses may eventually be shown to cause diarrhea and allowing us 
to begin to close the gap in our understanding of the causes of diarrhea.  
Significant technological developments within recent years have 
greatly enhanced our ability to detect both known and novel viruses as 
evidenced by the work presented in this dissertation as well as work done 
by others.   Continuing evolution of these technologies will certainly lead 
to further increases in this arena.   Critically, while the identification of 
novel viruses is becoming increasingly more facile, the discovery is merely 
the introductory chapter into each virus’ story.   For example, with each 
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new virus identified, there are a host of questions that arise regarding 
each virus’ tropism, epidemiology, and potential link to disease.   To 
answer these questions will require many years of further investigation, 
using myriad tools of biology, virology and medicine.  
The scientific questions that need to be addressed for each virus are 
initially all the same. The major questions for both AstV-MLB1 and AstV-VA1 
are whether they are actually human pathogens and if so, whether they 
do in fact cause diarrhea. These questions are difficult to answer short of 
doing human infection trials. The founding principles for demonstrating 
microbial pathogenesis are based on satisfying Kochs postulates. Today 
we know that Kochs postulates cannot always be satisfied for every 
pathogen. The reasons for this can vary from ethical considerations of 
carrying out human experiments to the fact that not all pathogens can 
be cultured, which is a requirement for satisfying the postulates.  
Culturing of these novel viruses may present a major challenge for 
future research investigations. Since traditional virus discovery methods 
relied heavily on the ability to culture viruses, one might argue that these 
viruses are unlikely to grow well under standard culturing conditions or else 
they would have already been discovered. There are many important 
humans pathogens that have proven difficult to culture such as human 
noroviruses and hepatitis C virus.  For these viruses, significant effort has 
been exerted since their discoveries in trying to get them to grow in the 
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laboratory. It might be the case that significant creativity as well as a lot of 
trial and error will be required to establish culturing conditions for these 
novel astroviruses. This is a very important direction for future research on 
these viruses because having a culturable virus makes exploring other 
scientific questions easier and also facilities production of vaccines and is 
useful for other translational applications.  
Kochs first postulate is that an organism must be found in all disease 
cases and in no healthy cases in order for it to be considered a pathogen. 
Again, we know that these absolutes are not always true, especially when 
considering a polymicrobial disease like diarrhea. There are many factors 
such as the host immune system, co-infecting microorganisms, and 
environmental factors that are speculated to be involved in viral 
pathogenesis, but the extent of how these factors affect different viruses is 
not well understood. However, if AstV-MLB1 and AstV-VA1 can be 
statistically associated with diarrhea cases rather than healthy cases, then 
that will provide compelling evidence to say that these viruses cause 
diarrhea. Therefore, screening large cohorts of case-controlled diarrhea 
specimens is also an essential next step for the progression of research on 
these viruses.  
Finally, some of the best evidence to demonstrate that these viruses 
infect humans is seroconversion upon exposure to the virus. It is assumed 
that the generation of antibodies implies that the virus actually infected 
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the host as opposed to having been passed through the gastrointestinal 
tract. Again since there are ethical concerns for doing human 
experiments with novel viruses about which very little is known, the best 
proxy for directly monitoring seroconversion is to examining existing 
immunity to these viruses in the general population. Seroprevalence 
studies can give us some information about how common these viruses 
are in the human population and potentially at what age people are 
frequently exposed to them.  
Historically, it has been postulated that the identification of novel 
viruses in a given specimen or syndrome is the rate-limiting step in 
addressing the question of disease causality.   With the advent of new 
technologies, a shift has occurred such that in many instances, the rate-
limiting step is no longer discovery but understanding the biological 
relevance and impact of newly discovered viruses. The application of 
unbiased, culture independent discovery methods has already yielded 
many fruit in the form of new viruses, which are likely to be just the tip of 
the proverbial iceberg.   Undoubtedly many additional new viruses will be 
uncovered in the upcoming years, thereby providing new substrates for 
investigation and understanding of virology, virus host interactions, virus-
environment interactions, and of course disease pathogenesis.  
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